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Abstract
A comparative analysis of the G1/S transition control in
kinetic models of the eukaryotic cell cycle
R. Conradie
Department of Biochemistry
University of Stellenbosch
Private Bag X1, 7602 Matieland, South Africa
Thesis:
December 2009
The multiplication of cells proceeds through consecutive phases of growth and division
(G1, S, G2 and M phases), in a process known as the cell cycle. The transition between
these phases is regulated by so-called checkpoints, which are important to ensure proper
functioning of the cell cycle. For instance, mutations leading to faulty regulation of the
G1/S transition point are seen as one of the main causes of cancer.
Traditionally, models for biological systems that show rich dynamic behavior, such
as the cell cycle, are studied using dynamical systems analysis. However, using this
analysis method one cannot quantify the extent of control of an individual process in
the system. To understand system properties at the process level, one needs to employ
methods such as metabolic control analysis (MCA). MCA was, however, developed
for steady-state systems, and is thus limited to the analysis of such systems, unless the
necessary extensions would be made to the framework.
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The central question of this thesis focuses on quantifying the control in mathemati-
cal models of the G1/S transition by the individual cell cycle processes. Since MCA was
never applied to the cell cycle, several new methods needed to be added to the frame-
work. The most important extension made it possible to follow and quantify, during a
single cell cycle, the control properties of the individual system processes.
Subsequently, these newly developed methods were used to determine the control
by the individual processes of an important checkpoint in mammalian cells, the restric-
tion point. The positioning of the restriction point in the cell cycle was distributed over
numerous system processes, but the following processes carried most of the control:
reactions involved in the interplay between retinoblastoma protein (Rb) and E2F tran-
scription factor, reactions responsible for the synthesis of Delayed Response Genes and
Cyclin D/Cdk4 in response to growth signals, the E2F dependent Cyclin E/Cdk2 syn-
thesis reaction, as well as the reactions involved in p27 formation. In addition it was
shown that these reactions exhibited their control on the restriction point via the Cy-
clin E/Cdk2/p27 complex. Any perturbation of the system leading to a change in the
restriction point could be explained via its effect on the Cyclin E/Cdk2/p27 complex,
showing a causal relation between restriction point positioning and the concentration of
the Cyclin E/Cdk2/p27 complex.
Finally, we applied the new methods, with a modular approach, to compare a number
of cell cycle models for Saccharomyces cerevisiae (budding yeast) and mammalian cells
with respect to the existence of a mass checkpoint. Such a checkpoint ensures that cells
would have a critical mass at the G1/S transition point. Indeed, in budding yeast, a
correction mechanism was observed in the G1 phase, which stabilizes the size of cells
at the G1/S transition point, irrespective of changes in the specific growth rate. This in
contrast to the mammalian cell cycle models in which no such mass checkpoint could
be observed in the G1 phase.
In this thesis it is shown that by casting specific questions on the regulation and
control of cell cycle transition points in the here extended framework of MCA, it is
possible to derive consensus answers for subsets of mathematical models.
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Die selsiklus bestaan uit agtereenvolgende groei- en delingsiklusse wat tot selvermeer-
dering lei. Die siklus word gekenmerk deur onderskeie fases (G1, S, G2 en M) wat
deur sogenaamde beheerpunte gereguleer word. Hierdie beheerpunte verseker dat sel-
vermeerdering nie ongekontroleerd kan plaasvind nie en mutasies wat lei tot foutiewe re-
gulering van die G1/S transisiepunt word as een van die hoofoorsake van kanker beskou.
Die hoofdoel van hierdie studie was om die beheer wat selsiklusprosesse op die G1/S
transisie uitoefen met behulp van wiskundige modelle te kwantifiseer. Omdat biologiese
sisteme soos die selsiklus ryk dinamiese gedrag vertoon, word hulle tradisioneeldeur
middel van dinamiese sisteemanalise bestudeer. Die analisemetode beskik egter nie oor
die vermoë om die hoeveelheid beheer wat afsonderlike sisteemprosesse op ′n sisteemei-
enskap uitoefen te kwantifiseer nie. Om sisteemeienskappe op prosesvlak te verstaan
moet metodes soos metaboliese kontrole analise (MKA) ingespan word. MKA was eg-
ter ontwikkel om sisteme in ′n bestendige toestand te analiseer en aangesien MKA nog
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nooit vantevore vir selsiklus analises gebruik was nie, moes nuwe MKA tegnieke gedu-
rende die studie ontwikkel word. Die belangrikste van die metodes maak dit moontlik
om beheer (soos uitgeoefen deur die onderskeie sisteemprosesse) oor ′n enkele selsiklus
na te volg en te kwantifiseer. Die nuut-ontwikkelde metodes was vervolgens gebruik
om te bepaal hoe een so ′n beheerpunt in soogdierselle - die restriksiepunt - deur die
onderskeie sisteemprosesse beheer word.
Die studie het aangedui dat die posisie van die restriksiepunt tydens die selsiklus
deur ’n verskeidenheid sisteemprosesse beheer word. Die bevinding was dat vier pro-
sesse beduidend meer beheer op die posisie van die restriksiepunt uitoefen: Reaksies
wat betrekking het op die wisselwerking tussen retinoblastoma proteïen (Rb) en E2F
transkripsiefaktor; reaksies verantwoordelik vir die sintese van vertraagde responsgene
en Siklien D/Cdk4 in respons tot groeiseine; die E2F afhanklike Siklien E/Cdk2 sin-
tesereaksie; sowel as die reaksies betrokke in p27 vorming. Daar was ook aangetoon
dat hierdie reaksies hul beheer op die posisie van die restriksiepunt deur die Siklien
E/Cdk2/p27 kompleks uitoefen, siende enige sisteemversteuringe (wat tot veranderinge
in die restriksiepuntposisie aanleiding gee) deur veranderinge in die kompleks verklaar
kon word - ′n observasie wat aandui dat daar ′n kousale verhouding is tussen die posisie
van die restriksiepunt en die Siklien E/Cdk2/p27 kompleks.
Die nuut-ontwikkelde metodes was verder gebruik om ′n verskeidenheid selsiklus-
modelle van Saccharomyces cerevisiae (bakkersgis) en soogdierselle met ′n modulêre
aanpak te vergelyk om te bepaal of daar ′n massa beheerpunt in beide soogdier- en bak-
kersgisselle bestaan. Daar word gepostuleer dat hierdie beheerpunt verseker dat selle
′n kritiese massa by die G1/S transisiepunt bereik. Die resultate van die studie dui
daarop dat bakkersgis, anders as soogdierselle, oor so ′n korreksiemeganisme beskik.
Die meganisme stabiliseer die grootte van selle in die G1 fase ondanks veranderinge in
die groeitempo van die selle, sodat massa homeostaties by die G1/S transisiepunt ge-
handhaaf word. Die studie het getoon dat moeilike vrae met betrekking tot die selsiklus
beantwoord kan word deur van wiskundige modelle gebruik te maak en die probleme in
die nuut-ontwikkelde metaboliese kontrole analise raamwerk te giet.
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Chapter 1
General Introduction
The bewildering diversity of biological systems has been a near-endless source
(and excuse) for biologists to isolate, identify and characterize components;
leading to descriptions of biological systems as lists of parts. These descriptions
have largely been qualitative; examples are lists of species in an ecosystem, or a
list of the molecular components in a cell. Such a list can be seen as a blueprint
for a system, which in itself is dead and not overly interesting, but forms a nec-
essary start to study interactions between the species. The rich and functional
behavior for which biological systems are known, stems from the interactions
between its components and forms the key question for the field known as Sys-
tems Biology: “How can systems behavior be understood as a function of its
components and their interactions?”
It is not essential to know all the components of a system to start analyzing
the interactions between them, and often a semi-quantitative understanding of
system behavior can be obtained by studying so called “core” - models, which
include a minimal subset of components and interactions of the system, still
leading to its characteristic behavior. Indeed, given the large number of compo-
nents and the non-linearity of their interactions, it is often necessary to focus first
on a subset of components and interactions. Even for such a subset of reactions
to be analyzed, good mathematical tools are necessary and although some core
models can be analyzed analytically, the vast majority of systems are analyzed
1
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numerically using kinetic computer models.
With the rapid developments in the different omics fields, large data sets have
become available, especially for the molecular parts of biological cells. In prin-
ciple these datasets are again lists of components, but now a new level of detail is
reached where the systems are completely described. The availability of exper-
imental datasets at this level of detail and the necessity to make sense of all this
information on a systems level have inspired new modeling approaches. As such
we distinguish two modeling approaches: in so called “bottom-up” approaches,
experimental data at the level of the components is used for model construction.
These models can be very detailed and tend to integrate our current knowledge
of the system, not so much attempt to fit the model on systems behavior. This in
contrast to “top-down” approaches where systems behavior is used to construct
the model10.
Mathematical models have traditionally been applied to a number of biolog-
ical disciplines such as ecology, neurology and metabolism. However, in most
biological fields, for instance the whole field of molecular biology and cell bi-
ology, there is still a strong focus on molecular characterization. Although, in
general, this also holds for the study of the cell cycle, where an enormous num-
ber of protein complexes are known to be involved, a number of research groups
have actively been building and using mathematical models, ranging from core
to detailed models, to describe the cell cycle.
Kinetic models are important tools for studying biological systems, not only
to get a quantitative description of the system and for data analysis, but also to
test hypotheses and to gain understanding. Specifically for the more detailed
models, it is important to use good analysis tools for the interpretation of the
model simulations. Traditionally, for systems displaying rich temporal behavior
such as oscillations, bistability and chaos, a framework, loosely defined as dy-
namical systems analysis is used. Typical analyses performed in this framework
include phase-plane, stability and bifurcation analysis, which are well suited for
smaller systems but are not ideal for large systems (e.g. more than fifty re-
actions). Many biological systems have simpler dynamic behavior and, when
kept in a constant environment, will reach a so-called steady state. Specifically
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for the quantitative analysis of such systems a mathematical framework called
metabolic control analysis (MCA) has been developed48,38,40. As its name sug-
gest the framework has been often applied (but is not limited) to metabolic sys-
tems and has addressed important issues such as rate-limiting steps, and differ-
ences between regulation and control. Importantly for Systems Biology studies,
the framework makes it possible to relate systemic properties to the characteris-
tics of its components.
At the beginning of my PhD study, MCA had never been used in cell cycle
studies, nor in the analysis of kinetic models of the cell cycle. Largely this could
be attributed to the dynamic behavior that such systems display, very different
from the steady states for which MCA was developed. A marked difference be-
tween the dynamical systems analysis and MCA is that in the first approach the
analysis is often made in terms of variables (for instance in phase-plane analy-
sis), while in the latter approach the analysis is cast in terms of processes, e.g.
what is the control of an enzyme on the steady state flux? MCA has played an
important role for the quantitative understanding of steady state systems, and
it would be very interesting to see if the framework could be extended to dy-
namic systems such as the cell cycle, and to test whether such a different ap-
proach would help in understanding this complex and important biological phe-
nomenon.
Cells reproduce by successive cycles of coordinated growth and division,
resulting in a daughter and mother cell. For bacterial cells and fission yeast, the
mother and daughter cells are identical, but for the budding yeast Saccharomyces
cerevisiae the daughter cell is smaller than the mother cell, and the mother cell
carries a scar for each bud she has produced. This process, called the cell division
cycle, or cell cycle is shown schematically in Figure 1.1.
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Figure 1.1: Coordinated growth and division cycles in Saccharomyces
cerevisiae. Growth during the consecutive G1, S and G2 phases followed
by the M phase (mitosis) and division are indicated for the budding yeast cell.
The cell cycle has been subdivided into the G1, S, G2 and M phases, pro-
gression between which is governed by checkpoints. The transition from the G1
phase to the S phase of the cell cycle is, in yeast, believed to be regulated by a
mass checkpoint and in mammalian species an additional checkpoint exists in
the form of the restriction point where cells assess the external conditions. Mu-
tations leading to a deregulation of the G1 to S transition have been shown to be
one of the main causes of cancer84,58, clearly illustrating the importance of its
control, the main subject of this thesis. Traditionally, cell biology and molec-
ular biology studies focus on key players in the cell division cycle, such as the
cyclins and cyclin dependent kinases and have shown that deregulation of these
key players leads to phenotypic aberrations of the wild type cell cycle.
In this thesis: “A comparative analysis of the G1/S transition control in ki-
netic models of the eukaryotic cell cycle” I address the following question: Is it
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possible to quantify the control exerted by the processes in the cell cycle network
on the checkpoints of G1/S transition?
To address this question we had to develop several new methods, which were
all based on the MCA framework. In Chapter 3 we extended this framework
such that it could be applied to any dynamical system, and illustrated the ap-
proach for limit cycle oscillations and for a transient response in simple core
models. Subsequently, using this method we analyzed the control distribution
for the positioning of the restriction point in the mammalian cell cycle in Chap-
ter 4. In addition, we reconciled the “species” and “processes” approaches, by
analyzing in detail the correlation between the control by the processes on both
the restriction point and the molecular species. In Chapter 5 we made a compar-
ative analysis using a modular approach for the control on the G1/S transition
and show that control on the G1/S transition is distributed over several processes
to ensure that the critical cell mass at the G1 to S phase transition is not greatly
compromised upon system perturbations.
We start with some background information on important topics that we treat
in detail in this thesis.
Chapter 2
Background information on
research topics
In this chapter I provide background information on the major research topics
and methods that I use in my thesis. This includes an introduction in systems
biology, modeling of the cell cycle and a short overview of metabolic control
analysis. Each of the subsequent chapters has an introduction of its own, but
these are rather short and immediately lead into the subject without extensive
background.
Systems biologists try to get a quantitative understanding of the functional
behavior of a biological system on the basis of the characteristics of its under-
lying components. A key methodology for the research field is the continuous
iterative cycling between experiment and mathematical modeling. In addition
to model validation, such cycles can also be used for the testing of hypothe-
ses generated from the model. Subsequent model analysis in a suitable math-
ematical framework, such as Metabolic Control Analysis (MCA) can lead to a
deeper understanding of emergent* system properties68,67,82,78. MCA is a rig-
orous framework48,38,40 that quantifies the control of reaction steps on system
properties. Originally MCA was developed to analyze steady state† behavior
*arising from the interactions of the components within a system.
†The stationary state in which the variables in a system remain constant in time but the
6
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(see Section 2.3) but later extensions have been made to also include dynamical
systems (Section 2.4).
Two different approaches have been used to construct mathematical models
of biological systems: firstly the “bottom-up” approach, which relies on detailed
information of the individual components and their interactions to examine the
mechanism through which a system property emerges10. The second approach,
called the top-down approach is more phenomenological ‡, and relies strongly
on system information for its construction10, whereas the “bottom-up” approach
uses such information only for model validation. Both of these approaches and
hybrids thereof have led to the construction of a multitude of detailed and core
models for biological systems.
In a previous contribution24 we have shown that MCA can be used to com-
pare the functional behavior of steady state models of erythrocyte metabolism.
In contrast to mathematical models of erythrocyte metabolism, mathematical
models of the cell cycle (see Section 2.2) are dynamic, non steady state mod-
els that are constructed using a mixture of top-down and bottom-up approaches.
After first introducing the biology of the cell cycle (Section 2.1), we will discuss
these models in further detail (Section 2.2).
2.1 Cell cycle control
The process by which cells duplicate their contents and divide into two daughter
cells is called the cell cycle or cell-division cycle. In eukaryotes the cell cycle is
divided into two visually distinct periods called interphase and mitosis. During
interphase the cell duplicates all its cellular components before undergoing mi-
tosis during which the cell segregates its duplicated chromosomes and divides.
Three separate phases are distinguished in the interphase: G1, S and G2.
The first gap phase (G1), in which proteins and RNA are synthesized, starts
reaction rates are non-zero
‡phenomenological models are not based on reaction mechanisms and, in most cases, they
do not include knowledge about the interactions that occur between the molecular components10
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directly after cell division and ends when DNA replication starts. This marks the
beginning of the S phase which runs until all DNA has been replicated, leading
to the second gap phase (G2), which lasts until the start of mitosis75,76,51,15,14.
Traditionally, progression through the cell division cycle is believed to de-
pend on discrete checkpoints, where a decision is made about transition to the
next phase. Two such points are defined close to the G1/S transition: a mass as-
sessing point and a restriction point. Both of these points are often referred to as
the G1/S checkpoint, and this has led to the misconception that both points reg-
ulate the G1/S transition point in the same way. The mass assessing point is usu-
ally referred to as START in yeast. At this checkpoint a size requirement must
be met before cells can transgress to the S phase, whereby balanced growth and
division is ensured. When the functioning of this checkpoint is compromised by
mutation, cells can become abnormally large or small76,55. In mammalian cells
it is unclear whether such a strict mass assessment point exists. In these cells a
restriction point is defined, which is a checkpoint where the cell senses external
growth queues on basis of which a decision is made whether to transgress from
the G1 phase to the S phase, or to enter the quiescent G0 phase. On the basis of
the condition that is checked, we will make a strict distinction between the two
G1/S checkpoints; to which we will refer as either mass assessing point or re-
striction point. Note that we will also make a distinction between checkpoints,
where a check on a condition is made, and transition points which marks the
actual transition from one phase to the next.
Along with the identification of the respective cell cycle phases and their
checkpoints, a reductionistic or protein-centric approach has been followed by
molecular and cell biologists to identify which proteins, regulate the respective
cell cycle checkpoints. The most important kinases and phosphatases involved in
the cell cycle regulation are the cyclins and cyclin dependent kinases (Cdks). The
interaction between the cyclins and the anaphase-promoting complex (APC),
which consists of a group of polypeptides and two auxilliary proteins (Cdc20
and Cdh1), is necessary to sustain a cell division cycle.
At the core of the cell cycle is a bistable loop emerging from the antagonism
between the cyclin/Cdks and APC. During the G1 phase the Cdh1/APC concen-
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tration is high and the cyclin/Cdk concentrations are low. The G1 to S phase
transition is marked by a rapid increase in cyclin/Cdk concentrations and a de-
crease in the Cdh1/APC concentration (Figure 2.1). Additional bistable loops
exist within the cell cycle to act as further points of regulation. An example is
the antagonism between the retinoblastoma (Rb) protein and the E2F transcrip-
tion factor essential for the establishment of the restriction point84.
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Figure 2.1: The cell cycle. The bistable loop between APC and Cyclin/Cdk
is essential to establish a cell division cycle. The central cartoon of the molec-
ular interactions between APC and Cyclin/Cdk was adapted from76.
The picture we have drawn thus far is a huge simplification of the total cell
cycle network as it is currently envisioned (see Figure 2.2)51, here shown to
illustrate the complexity of the network. The vastness of the network, as well
as the richness of the behavior of even a small number of proteins necessitates
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the use of mathematical models to quantitatively understanding regulation of the
cell cycle.
Figure 2.2: The mammalian cell cycle molecular interaction map as set out
by Kohn51.
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2.2 Mathematical modeling of the cell cycle
Several research groups construct deterministic mathematical models of the eu-
karyotic cell cycle. Of these groups, Bela Novak’s group from the University
of Oxford and John Tyson’s group from the Virginia Polytechnic Institute and
State University are amongst the most active. Both these groups follow roughly
the same methodology to construct their models - using ordinary differential
equations (ODEs) to represent a minimal wiring diagram that, according to
the current experimental knowledge, best describes the system under study. In
this section we briefly introduce the methodology that is generally followed for
the construction of cell cycle models described in terms of ordinary differential
equations.
An ordinary differential equation describes how processes within a system
affect the rate of change of a variable (X):
{rate of change of X} = { sum of rates of processes producing X} −
{ sum of rates of processes consuming X}
or, more formally written as
dX
dt
=
p∑
i=1
vproductioni −
c∑
i=1
vconsumptioni (2.2.1)
where the rates of the processes v are summed for the total number (p) of re-
actions producing X substracted by the total number (c) of reactions consuming
X.
The most predominant equations used to describe processes in the cell cycle
are mass action kinetics (equation 2.2.2a), Michaelis-Menten kinetics (equation
2.2.2b) and Goldbeter-Koshland zero-order ultrasensitivity switches (equation
2.2.2c)31,27.
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Examples of rate equations used in cell cycle modeling:
vmass action = k1A[t]B[t] (2.2.2a)
vmichaelis-menten =
VmaxA[t]
km + A[t]
(2.2.2b)
d
dt
X[t] =
V1(X[t]tot − X[t])
K1 + X[t]tot − X[t] −
V2X[t]
K2 + X[t]
(2.2.2c)
where in equation (2.2.2a), k1 represents an elementary rate constant and
A[t] and B[t] are two variable species that linearly affect the rate vmass action. In
equation (2.2.2b), used for enzyme catalyzed reactions, the rate vmichaelis-menten
is affected by a single specie, A[t], and is dependent on two parameters - Vmax,
the maximum velocity of the reaction and KM, the Michaelis constant which de-
scribes the affinity of the enzyme for its substrate. If an enzyme can exist in two
different forms, of which only one is active, and if it displays abrupt switching
between the two forms, a zero-order ultrasensitivity switch can be used to math-
ematically describe the switching behaviour. Assuming X[t] is the active form,
the equation can be expressed as equation (2.2.2c) where V1 is the activation
rate, V2 is the inactivation rate and K1 and K2 are Michaelis constants.
Once a set of ODEs has been chosen to describe the wiring diagram of the
cell cycle, an attempt is made to fit model parameters on experimental obser-
vations. If the set of ODEs fails to describe the experimental observations, the
ODEs are adapted, followed by further parameter fitting until the set of ODEs
can accurately describe the experimental observations of mutant and wild type
cells. The most elaborate budding yeast cell cycle model currently available14
for which this model construction method was used, is able to describe the phe-
notypic observations of 131 mutant strains.
2.3 Traditional Metabolic Control Analysis
Metabolic Control Analysis48,38,40 is a mathematical framework that quantifies
the dependencies of steady state properties such as flux or metabolite concentra-
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tions on process activities. These dependencies are expressed in control coeffi-
cients, which can operationally be defined as the % change in a system property,
X, upon a 1 % perturbation of a specific process activity, vi. In mathematical
terms:
CXvi =
∂lnX
∂lnvi
=
∂X/X
∂vi/vi
(2.3.1)
An important property of control coefficients is that, for any flux, the control
coefficients of all the processes within the system sum to unity (the flux-control
summation property) and, for any concentration, the control coefficients of all
the processes within the system sum to zero (the concentration-control sum-
mation property).
Expressed mathematically as:
n∑
i=1
CJi = C
J
1 + C
J
2 + . . . = 1 (2.3.2a)
n∑
i=1
Cxi = C
x
1 + C
x
2 + . . . = 0 (2.3.2b)
The summation theorems illustrate that the control on a system property can
be shared between the processes in a system. The ability to quantify the control
of a process was a major improvement from the notion of a rate-limiting step.
In addition to showing that control exerted on a system property can be dis-
tributed between the system processes (refer to equation (2.3.2a)), MCA en-
ables one to express the systemic control coefficients in terms of local properties.
The connectivity theorems link the control coefficients to elasticity coefficients
which can operationally be defined as the % change in a reaction rate, vi, upon a
1 % perturbation of a parameter for the isolated reaction.
An elasticity coefficients can be expressed mathematically as:
vix =
∂lnvi
∂lnx
=
∂vi/vi
∂x/x
(2.3.3)
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We do not go in great detail on the applications of elasticity coefficients as
they do not play an important role in the MCA for dynamic systems as treated in
this thesis.
2.4 Metabolic Control Analysis for dynamic
systems
Metabolic Control Analysis (MCA) is mostly used to analyze time invariant
properties of steady state systems. However, dynamical systems exhibit both
time dependent and time independent behaviour. Examples of time dependent
system properties for dynamic systems are reaction rates and metabolite concen-
trations, which vary with time (for instance in an oscillatory system), while time
independent system properties such as oscillation frequency are constant in the
limit cycle.
Several extensions to MCA have been made to analyze the control on time
independent system properties of oscillatory systems such as frequency, aver-
age value, amplitude, waveform, phase shift, period, local minima, and local
maxima8,49,22,61,63,62,47,45.
MCA for time dependent system properties has been made by44 for which
time dependent control coefficients were used, which are not useful for the anal-
ysis of the cell cycle. The control analysis of the cell cycle, and specifically its
time dependent properties are important for the work presented in this thesis. In
Chapter 3, we will treat in detail our extension to MCA for these systems.
Chapter 3
Summation theorems for flux and
concentration control coefficients of
dynamic systems*
3.1 Abstract
Metabolic Control Analysis (MCA) was developed to quantify how system vari-
ables are affected by parameter variations in a system. In addition, MCA can
express the global properties of a system in terms of the individual catalytic
steps, using connectivity and summation theorems to link the control coeffi-
cients to the elasticity coefficients. MCA was originally developed for steady
state analysis and not all summation theorems have been derived for dynamic
systems. A method to determine time-dependent flux and concentration control
coefficients for dynamic systems by expressing the time domain as a function of
percentage progression through any arbitrary fixed interval of time is reported.
Time-dependent flux and concentration control coefficients of dynamic systems,
provided that they are evaluated in this novel way, obey the same summation the-
*The work presented in this chapter was published: Conradie, R; Westerhoff H V; Rohwer
J M; Hofmeyr J H S; Snoep J L (2006) Summation theorems for flux and concentration control
coefficients of dynamic systems. IEE Proc. Syst. Biol. 153(5): 314-7.
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orems as steady-state flux and concentration control coefficients, respectively.
3.2 Introduction
MCA is a theoretical framework that was initiated by Kacser and Burns48 and
Heinrich and Rapoport38,39. One motivation was to quantify how system vari-
ables (such as concentrations of metabolites and fluxes through a metabolic path-
way) change in response to parameter variations (perturbations) such as changes
in enzyme concentrations. A further motivation for developing MCA was to
describe the global regulatory properties of a system of reactions in terms of
properties of the individual catalytic steps. These goals have been achieved
in the form of control, elasticity and response coefficients as well as summa-
tion and connectivity theorems. Traditionally control coefficients quantify the
change that a steady state variable, such as flux and concentration, undergoes
when a small change is made to the activity of an independent process step in
the system. Elasticity coefficients, on the other hand, quantify to what extent
the rate of an independent process in a system is changed immediately upon a
change of any molecular species or parameter that affects that process directly.
The relations between these coefficients are given by the summation and con-
nectivity theorems, which make it possible to express the systemic regulatory
properties in terms of the characteristics of the individual steps48,38,39, thereby
making MCA an ideal tool for system biologists. In accordance with the sum-
mation theorem, numerous ideas regarding metabolism, such as the existence of
a rate-limiting step in a metabolic pathway have been replaced with a rigorous
quantitative description, e.g. the control of a pathway is distributed among the
different catalytic steps of the pathway.
MCA has been implemented successfully vis-à-vis many metabolic systems
that exhibit steady state behaviour. Traditional MCA was not able to describe dy-
namical systems where temporary or permanent variations of metabolic fluxes
and concentrations are significant. Advances in experimental techniques and the
realization that many cellular mechanisms can only be understood on the basis
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of their dynamical behaviour have led to an increase in the number of investi-
gations of dynamical systems (i.e. calcium waves, neuronal signal oscillations,
cAMP oscillations, signal transduction pathways and the cell cycle). Therewith,
the potential assets of a method that can contribute to our understanding of dy-
namical systems in ways similar to the ways in which MCA has contributed to
understanding steady-state systems, have become more evident.
One of the first extensions to traditional MCA, so that it can describe dynam-
ical systems, was to introduce a time-dependent control coefficient3. Unfortu-
nately this formulation could not be generalized to all dynamical systems as it
does not appear to be very useful for describing autonomously oscillating sys-
tems because the magnitude of the time-dependent control coefficient diverges
as time progresses49,22. Acerenza and Kacser2,1 then analysed the control prop-
erties of time-invariant variables with dimensions of time (i.e. relaxation time
and period of oscillation) of time-dependent systems by MCA and also deduced
summation theorems for them. Unfortunately the variables traditionally ana-
lyzed with MCA in steady state systems (i.e. fluxes and concentrations) are not
just time-invariant variables with dimensions of time and hence cannot be deter-
mined as proposed by Acerenza and co-workers. Also, extensions to standard
MCA proposed by Heinrich and Reder41 cannot be generalized to all dynamical
systems because concentrations of metabolites are not necessarily in the vicinity
of a steady state49,22. As a result, MCA-like approaches for time independent
variables of autonomously oscillating systems such as frequency, amplitude, av-
erage value, waveform, phase shift49,22,80,8,61,63 and for signal transduction path-
ways (i.e. signal maximum (amplitude), its ultimate value (final strength), its
duration and its time-integrated concentration) have been performed44. A for-
mal mathematical description of sensitivity analysis on extrema and period of
autonomously oscillating systems has been developed45.
It has hitherto not been possible to quantify the control that each reaction step
of a dynamical system plays in regulating fluxes and metabolite concentrations.
In this contribution we show how time-dependent flux and concentration control
coefficients can be determined for dynamical systems when the time domain is
treated as percentage progression through any arbitrary fixed interval of time.
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Furthermore, we show that steady state flux and concentration control summa-
tion theorems also hold for dynamical systems. Lastly, we illustrate the approach
using a kinetic model of a system with temporary variations (a signal transduc-
tion model) as well as a system with permanent fluctuations (an autonomously
oscillating system).
3.3 Methods
The work of Acerenza and coworkers3,2,1 has shown that upon multiplication of
all rate equations of a system (β) with a constant factor (d) the new system (βd)
can be described as a function of β. This corresponds to a time transformation
from t = 0 onwards22,44. The time dependence of the state variables in βd, sd(t),
can be expressed as a function of the state variables in β(s(t)) as follows:
s(t) = sd(t/d) (3.3.1)
Any time point (t) in an arbitrary fixed length of time (T ) between time t0
and time t0 + T can be expressed as:
t = t0 + t1, t1 = 0, ...,T (3.3.2)
with:
t1 = zT, z = 0, ..., 1 (3.3.3)
where z is the fraction of progression through the interval, i.e. the phase
[t0, t0 + T ].
Combining equations 3.3.1, 3.3.2 and 3.3.3 we obtain:
s(t0 + zT ) = sd((t0/d) + z(T/d)) (3.3.4)
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Thus, the concentration of any metabolite at a certain percentage progression
through one arbitrary fixed interval of time in system β would be the same as the
concentration of that metabolite in system βd at the same percentage progression
(at the same phase). Furthermore, since the metabolite concentrations at the
same percentage progression are constant, the fluxes will increase proportionally
with d (the multiplier of the reaction rates).
This implies that, when expressing the time domain as a function of percent-
age progression through an arbitrary fixed time interval, time dependent concen-
tration control coefficients and time dependent flux control coefficients sum to
0 and 1 respectively at any percentage progression through that interval. This
proof is valid for systems engaging in regular oscillations, i.e. repetitions with
time independent period T . For the proof for transient conditions we define T
so as to correspond to a point in time with a certain magnitude of a variable Xi.
Then the proof proceeds further as above, with the difference that z may exceed
1.
It is crucial that the control coefficients used here are evaluated in a special
way: the activity of any process i is increased by p% and the new concentration
is read p% earlier. This is then repeated for all processes, and the results are
summed over all processes. In this sense the control coefficients defined here
are not standard control coefficients. For these, the effect of the p% change in
enzyme activity is read at the same time. Then, then at least for transients the
sum of the concentration control coefficients should not equal zero but the time
control coefficient44.
To illustrate the approach, MCA was performed on the oscillatory phospho-
fructokinase (PFK) model developed by Goldbeter and coworkers32,30 as well
as on a kinetic model exemplifying the mechanisms of signal transduction con-
structed by Hornberg et al.44.
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3.4 The models
3.4.1 A dynamical system with permanent variations with
time
The phosphofructokinase (PFK) model developed by Goldbeter and cowork-
ers32,30, is a core model that describes the dynamic behaviour of glycolysis in
terms of the kinetics of the enzyme PFK. The model can be accessed and run on
JWS Online (http://jjj.biochem.sun.ac.za/database/goldbeter/index.html). The
variables α[t] and γ[t] denote the substrate concentrations (fructose 6-phosphate
or ATP) and product concentrations (fructose 1,6-bisphosphate) respectively.
Reaction 1 denotes the constant injection rate of substrate and reaction 3 the
constant rate of product removal. Reaction 2 encapsulates the most important
kinetic details of PFK along with the rate constant (or enzyme concentration).
3.4.2 A dynamical system with transient variation
The kinetic model by Hornberg et al.44 was constructed to elucidate the princi-
ples governing the control of signal transduction. The model represents a simple
linear pathway that consists of a receptor and three consecutive kinase/phosphatase
monocycles. The model represents a simplified MAP kinase pathway where the
active receptor R (activated by reaction 1) phosphorylates (activates) X1 to X1P.
In turn, X1P acts as a kinase by phosphorylating X2 to X2P. X2P then finishes
the three step phosphorylation by activating X3 to X3P. These phosphorylation
steps are denoted by reactions 3, 5 and 7. Reaction 2, 4, 6 and 8 encapsulates
the phosphatase reactions recycling the active species back to Ri, X1, X2 and
X3. The authors used signal amplitude A (i.e. the maximum concentration of
X3P attained) and the duration of signalling b (i.e. the time point where the con-
centration of X3P dropped below an arbitrary threshold value of 5% of total X3
(=0.05)) to perform their analyses. This model can be viewed and run on JWS
Online (http://jjj.biochem.sun.ac.za/database/Hornberg/index.html).
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3.5 Results and Discussion
3.5.1 A dynamical system with permanent fluctuations
Time simulations for the PFK model with variables α[t] and γ[t] and time simu-
lation of the same PFK model but with all the rates multiplied by the same arbi-
trary constant d (d = 0.95) with variables αd[t] and βd[t] are shown in Fig. 3.1.
Figure 3.1: Time simulations of the PFK model (solid lines) with variables
α[t] and γ[t] and the same PFK model but with all the rates multiplied by the
same arbitrary constant d (dashed lines) with variables αd[t] and γd[t].
Fig. 3.1 shows that the amplitude of α[t] and αd[t] are equal, as are the am-
plitudes of γ[t] and γd[t], which is in agreement with the summation theorem
for amplitude. In addition, the frequency of the system is changed with a con-
stant factor d. This is in agreement with the summation theorem for frequency.
t0 and T are time invariant properties of the system with dimensions of time.
When multiplying all rate equations by a factor d they transform into (t0/d) and
Chapter 3. Control Analysis for Dynamic Systems 22
(T/d) respectively2,1 (see Fig. 3.1). Even though these two systemic parameters
are scaled by d, the concentrations of metabolites in both systems are identical
when compared at the same percentage progression (z) through [t0, t0 + T ], i.e.
α[t] = αd[t/d] and γ[t] = γd[t/d].
Figure 3.2: Concentration control coefficients (Cα[t]1 , C
α[t]
2 , C
α[t]
3 ) and the sum
of these control coefficients,
∑3
i=1 C
α[t]
i , as a function of percentage progres-
sion through one oscillatory period.
This method was used to perform a control analysis on the PFK oscillatory
system. Results obtained from this analysis are depicted in Fig. 3.2 and Fig. 3.4.
The control analysis, for which the time domain is expressed as a function of
percentage progression through one period, confirmed that the steady state sum-
mation theorem for concentration control coefficients (
∑n
i=1 C
S
i = 0) also holds
for oscillatory systems (Fig. 3.2). Similarly, it can be seen from Fig. 3.3 that
the steady state summation theorem for flux control coefficients also holds for
oscillatory systems i.e.
∑n
i=1 C
J
i = 1.
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Figure 3.3: Flux control coefficients (Cv21 , C
v2
2 , C
v2
3 ) and the sum of these
control coefficients,
∑3
i=1 C
v2
i , as a function of percentage progression through
one oscillatory period.
3.5.2 A dynamical system with transient variation
The signal transduction model constructed by Hornberg et al.44 was used to de-
termine the control that the respective processes exert on signalling amplitude
of X3P (A), duration (b) of signalling (i.e. when X3P reaches a concentration
of 0.05), the integral of X3P over time (i.e. the area under X3P until it reached
b) and the final signalling amplitude (i.e. the concentration of X3P at steady
state)44. A simulation of this model and the values of A and b can be seen in
Fig. 3.4.
MCA was performed to determine the time dependent concentration and time
dependent flux control coefficients. The arbitrary fixed interval of time selected
to perform our analyses had a lower bound of zero and an upper bound of time
b where X3P reaches a threshold value of 5% of total X3 (=0.05). Hornberg et
al.44 grouped the various reactions into two functional groups called activating
processes (reactions 2, 3, 5 and 7) and deactivating processes (reactions 1, 4, 6
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Figure 3.4: Time course of the signal transduction model constructed by
Hornberg et al. The varying concentrations of metabolites X1P, X2P and
X3P are shown along with the maximum concentration value (A) reached by
metabolite X3P. The time (b) at which X3P reaches an arbitrary value of 0.05
is also shown.
and 8). We also used the same grouping and calculated the control the activating
processes have on the flux from X3 (inactive signalling molecule) to X3P (active
signalling molecule) and the control the deactivating processes have on the same
flux. The time course of these two control coefficients, Cv7activators and C
v7
deactivators,
as well as
∑8
i=1 C
v7
i are shown in Fig. 3.5.
Our analyses show that the control of flux from X3 (inactive signalling molecule)
to X3P (active signalling molecule) is, at the beginning of the signal, controlled
by the kinases. However, at a higher percentage progression, the control ex-
erted on the flux by the activating processes decreases. The signalling system
then momentarily reaches a state where both the activating and deactivating pro-
cesses have the same control over flux v7. When approaching time point b the
control on the flux that creates active signalling molecules is taken over by the
deactivating reactions until the signal is dissipated.
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Figure 3.5: Flux control coefficients of activators and deactivators(Cv7activators
and Cv7deactivators) and the sum of all control coefficients on rate v7,
∑8
i=1 C
v7
i , as
a function of percentage progression through the interval [0, b]. b is the time
where the concentration of X3P reaches a value of 0.05.
3.6 Conclusion
We have developed a method, based on the expression of time as a function of
percentage progression of a chosen time interval, for MCA of dynamic systems.
Using the method, we could show that the same summation theorems that hold
for concentration control coefficients and flux control coefficients of steady-state
systems also hold for dynamic systems. The generic method developed in this
article has been used to analyse a range of autonomously oscillating systems, re-
gardless of whether the oscillations are of a continuous or a discontinuous nature.
Furthermore, our method not only works for dynamic systems with sustained
variations (oscillations) but also for dynamic systems with transient variations
such as in signal transduction.
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3.8 Proof of the relationship between progression
control coefficients and time-dependent
control coefficients
The proof set out here was a contribution made by us in the Journal of Mathe-
matical Biology82. In the progression control coefficient the perturbation of the
phase of the response is corrected for by determination of the control coefficients
at a given progress point (corresponding to the phase in a periodic phenomenon).
That perturbation of phase is the essence of the time control coefficients. The re-
lation between the two types of control coefficients can be described as:
Cci(t)j = C
ci(pA)
j −Cci(t)t CAj (3.8.1)
where the control by reaction j on the concentration ci at a fixed time point
t is expressed as a function of the concentration control by j at a point in the
progress curve corresponding to t (i.e. pA) and the control by time on the con-
centration, multiplied by the control of reaction j on the length of the progress
curve (A). The latter control measures the extent to which the modulation of
reaction j stretches (retards) the time dependence of the process.
The analysis is valid for any type of dynamic behavior and the point A can be
set as a threshold of a concentration but can also be the maximum of a periodic
signal. One of the advantages of using the progression control analysis is that it
is not sensitive to the growing dispersion between the original and the perturbed
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signal, which is especially important for analyses over a prolonged time period,
for instance when analyzing a periodic signal.
Summation of equation 3.8.1 over all the reaction steps yields:
n∑
j=1
Cci(t)j =
n∑
j=1
Cci(pA)j −Cci(t)t
n∑
j=1
CAj (3.8.2)
with
n∑
j=1
CAj = −1 (3.8.3)
and
n∑
j=1
Cci(pA)j = 0 (3.8.4)
which reduce Eq. 3.8.2 to
0 = −Cci(t)t +
n∑
j=1
Cci(t)j = 0 (3.8.5)
Eq. 3.8.5 is the time dependent summation law for concentration control
coefficients44. This shows that correction for the phase-shift renders the classical
summation theorem. Below a more detailed proof for the relationship between
progression control coefficient and time-dependent control coefficient is given†
(Figure 3.6 is a figure to aid in explaining the proof):
A time-dependent control coefficient is defined as,
δ ln x(t, v j) =
∂ ln x
∂ ln v j
(t, v j)δ ln v j = Cxj (t)δ ln v j (3.8.6)
†Extended proof was derived by Frank J. Bruggeman.
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Figure 3.6: A geometrical interpretation of the proof set out below; The time
course for the unperturbed oscillation; Phase τ and the perturbed oscillation;
Phase τ∗.
It corresponds to the difference in a state variable between a perturbed and
an unperturbed system.
The progression control coefficient is defined for oscillatory systems at a time
point for the perturbed system that correspond to an equal progression along the
oscillation (phase, t/τ; with τ as period). If we define t + δt as the correct time in
the perturbed network, such that it has the same phase as the unperturbed system,
then we obtain,
δ ln x(t + δt, v j) =
∂ ln x
∂ ln v j
(t, v j)δ ln v j + (
∂ ln x
∂ ln t
(t, v j))τ f ixedδ ln t (3.8.7)
Thus for the perturbed system, we have as the reference time t + δt = t∗ and
phase τ∗. δt has been chosen such that t/τ = t∗/τ∗; to ascertain such that the
phase is preserved,
δ ln t = δ ln τ =
∂ ln τ
∂ ln v j
δ ln v j (3.8.8)
The progression control coefficient Cx(t−δt)j is defined as:
Chapter 3. Control Analysis for Dynamic Systems 29
δ ln x(t + δt, v j) = (
∂ ln x
∂ ln v j
(t, v j) +
∂ ln x
∂ ln t
(t, v j)
∂ ln τ
∂ ln v j
)δ ln v j (3.8.9)
= (Cxj (t) + C
x
t (t)C
τ
j)δ ln v j (3.8.10)
= Cx(t+δt)j δ ln v j (3.8.11)
Therefore,
Cx(t+δt)j = C
x
j (t) + C
x
t (t)C
τ
j (3.8.12)
=⇒ Cxj (t) = Cx(t+δt)j −Cxt (t)Cτj (3.8.13)
Equation 3.8.13 corresponds to equation 3.8.1 also described in the Journal
of Mathematical Biology82.
Given
n∑
j=1
Cx(t+δt)j =
n∑
j=1
Cxj (t) + C
x
t (t)
n∑
j=1
Cτj (3.8.14)
and since
n∑
j=1
Cτj = −1 (3.8.15)
n∑
j=1
Cxj (t) =
d ln x
d ln t
= Cxt (t) (3.8.16)
we obtain for the summation theorem:
n∑
j=1
Cx(t+δt)j = C
x
t (t) −Cxt (t) · 1 = 0 (3.8.17)
Chapter 4
Restriction Point Control of the
Mammalian Cell Cycle via the
Cyclin E/Cdk2:p27 Complex *
4.1 Summary
Numerous kinetic models, employing a mixture of top-down and bottom-up ap-
proaches, have been constructed to describe the cell cycle. These models have
typically been constructed, validated and analyzed using model species (molec-
ular intermediates and proteins) and phenotypic observations, and therefore do
not exclusively focus on the individual model processes (reaction steps). We
have developed a method to: 1) quantify the importance of each of the reaction
steps in a kinetic model for the positioning of a switch point (here the restric-
tion point); 2) relate this control of reaction steps to their effects on molecular
species, using sensitivity and co-control analysis; and thereby 3) go beyond a
correlation towards a causal relationship between molecular species and effects.
*The work presented in this chapter was accepted for publication: Riaan Conradie, Frank
J. Bruggeman, Andrea Ciliberto, Attila Csikász-Nagy, Bela Novák, Hans V. Westerhoff, Jacky
L. Snoep (August 2009) Restriction Point Control of the Mammalian Cell Cycle via the Cyclin
E/Cdk2:p27 Complex. FEBS Journal.
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The method is generic and can be applied to responses of any type but is most
useful for the analysis of dynamic and emergent responses such as switch points
in the cell cycle. The strength of the analysis is illustrated for an existing mam-
malian cell cycle model focusing on the restriction point (RP)56.
The reactions in the model with the highest RP control were those involved
in: 1) the interplay between retinoblastoma protein (Rb) and E2F transcrip-
tion factor; 2) those synthesizing the delayed response genes (DRG) and Cy-
clin D/Cdk4 in response to growth signals; 3) the E2F dependent Cyclin E/Cdk2
synthesis reaction, as well as 4) p27 formation reactions. Nine of the 23 interme-
diates were shown to have a good correlation between their concentration control
and RP control. Sensitivity and co-control analysis indicated that the strongest
control of RP is mediated via the Cyclin E/Cdk2:p27 complex concentration.
Any perturbation of the RP could be related to a change in the concentration
of this complex; apparent effects of other molecular species were indirect and
worked always through Cyclin E/Cdk2:p27, indicating a causal relation between
this complex and the positioning of RP.
4.2 Introduction
Arthur Pardee58 defined the restriction point (RP) as the apparent switch point
in the late G1 phase, beyond which normal cells would only progress when sup-
plied with a sufficient, mitogen containing culture medium. Once the cell has
transgressed the RP, the necessity of a mitogen (i.e. growth factor) containing
medium was relieved and cells will commit to replicate their DNA (S-phase)
and complete the remainder of the division cycle autonomously60,9. Cells in the
G1-phase that have not yet passed RP, monitor their environment and own size
to determine whether they are ready to commit to S-phase entry and division
cycle completion or, in contrast, enter the resting G0-phase60, where most non-
cancerous somatic mammalian cells spend their lifetime. Disregulation of the
RP has been linked to several disease states, most notoriously cancer58,84, and
quantification of the contribution of the different reaction steps in the cell cycle
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to the control of the RP would be important for drug target identification studies
and for understanding the action mechanism of existing, RP affecting drugs.
Abrupt cell cycle transitions (e.g. G1/S) are properties of the complete under-
lying control system which can be described without the necessity to introduce
hypothetical regulatory proteins or hard code a decision event56,7. Numerous
kinetic models that incorporate the existing knowledge of the molecular mecha-
nism of the restriction point have been constructed36,56,4,33. Novak and Tyson56
constructed their kinetic model on the RP of the mammalian cell cycle using
a yeast-like core model of the cyclin-Cdk interactions (emphasizing the deep
similarities of the yeast and mammalian cells Cdk-regulatory system). They
extended this core model with kinetic modules for the growth factor sensing
machinery of mammalian cells; the retinoblastoma and E2F transcription factor
interactions and the antagonism between the cyclin-dependent kinase inhibitor,
(p27Kip1), and Cyclin A/Cdk2 and Cyclin E/Cdk2. With their kinetic model, No-
vak and Tyson could account for the Zetterberg and Larsson experiments, which
proved the existence of RP and positioned it somewhere in the G1 phase85: (i)
cells pulse treated (1h) with cycloheximide early in the cell cycle (before RP)
immediately suffer a long delay in the cell division cycle, (ii) cells treated late in
the division cycle finish the current cycle similar to untreated cells but are sig-
nificantly delayed in the subsequent division cycle and (iii) cells treated directly
after the restriction point do not suffer any delays in the current or subsequent
division cycles.
Kinetic models that are constructed on the basis of known biochemical in-
formation about the system and its components, are routinely used to integrate
this knowledge and compare the resulting simulations with experimental obser-
vations. More extensive analysis methods are necessary to quantify the impor-
tance of each of the reaction steps for the systemic behavior. Metabolic Control
Analysis (MCA)48,38 is a rigorous framework that enables one to assess how a
biological function is controlled by the various molecular processes in the cell
sustaining that function. MCA has been used predominantly to analyse the con-
trol distribution in steady states, although the theory has been generalised for
systems with dynamic behavior63,47,49,22,19. In this contribution we develop and
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implement an extension to MCA that can be used not only to quantify the con-
trol of system variables, but also to infer via which molecular species this control
was elicited.
Our approach is well suited for systems biology studies where the primary
goal is to come to a quantitative understanding of systemic properties (such as
the emergent restriction point in the mammalian cell cycle) in terms of the mul-
titude of reaction steps and interactions between the cell’s molecular parts (such
as cell cycle proteins)68. Numerous researchers have recognised the need for
theoretical approaches in molecular biology54,34,53,57,29,52. Our novel framework
would be useful for molecular and systems biologists to determine which reac-
tions exert important control on a high-level system property, and explain via
which molecular species these reaction steps exert control.
Applying our approach to the RP, as modeled in the kinetic model devel-
oped by Novak and Tyson56, revealed that the control of RP was distributed over
the different reaction steps in the network. The highest control was exerted by
the reactions responsible for: 1) the interaction between retinoblastoma protein
(Rb) and E2F transcription factor; 2) synthesis of DRG and Cyclin D/Cdk4 in
response to growh signals; 3) the E2F dependent Cyclin E/Cdk2 synthesis re-
action; and 4) the p27 formation reactions. In addition, our analysis revealed
that RP control was exerted via the Cyclin E/Cdk2:p27 complex. Independent of
which reaction step or which molecular species was perturbed, all effects on the
restriction point could be explained via an effect of the perturbation on Cyclin
E/Cdk2:p27.
4.3 Model, Methods and Theory
The model presented by Novak and Tyson56 consisted of 18 ordinary differential
equations (ODEs) and several algebraic equations. Each of these ODEs were
used, along with the wiring diagram of the mammalian cell cycle network, to
distil 52 reaction steps from the network such that each step formed a functional
unit within the network. The retinoblastoma and E2F transcription factor in-
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teractions which were coded as steady state algebraic equations in the original
model were coded explicitly as ODEs, increasing the number of ODEs to 23
(see Appendix 1). The reaction network of the cell cycle model is schematically
represented in Figure 4.1.
Mathematica 6.0 was used for all simulations. The ODEs were solved using
the NDSolve function in combination with the EventLocator method to precisely
locate events during the simulation. A simulation result in which the restriction
point and the different phases of the cell cycle are indicated, is shown in Figure
4.2.
MCA is a theoretical framework that can be used to calculate the importance
of each of the steps in a reaction network for the systemic behavior, using so-
called control coefficients48,38. We used a perturbation method for calculating
control coefficients by adding a multiplier to each of the 52 steps (α1 to α52)
and perturbing each reaction individually (0.1 per million perturbation up and
down). After each perturbation the model was simulated until a new limit cycle
was reached and then control coefficients for stationary behavior, e.g. position
of RP or the length of the G1 phase, were calculated and expressed as a frac-
tion of the cell division cycle. For non-stationary behavior (i.e. time dependent
variables such as concentrations of metabolites or flux values for reaction steps)
an extension of MCA was used that enables the determination of control coeffi-
cients as the system progresses through an arbitrary fixed interval of time (e.g.
the cell division cycle), for a detailed description of the method see19 (Chapter 3
in this thesis).
Results and Discussion
Control of the Restriction Point
We used a perturbation method to quantify the control of the respective reaction
steps in a mammalian cell cycle model on the time of occurrence of the restric-
tion point, CRPi . The analysis revealed (Figure 4.3) that the control is distributed
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over the reaction network with the majority of the reactions steps exerting a
small to moderate control (|CRPi | < 1). Eight reaction steps exerted a high con-
trol (|CRPi | > 2) on the restriction point; four of which caused a delay (positive
control) while the others advanced the restriction point (negative control). The
CRPi for all reaction steps sums up to 0, this is to be expected on the basis of our
definition of RP as a fraction of the cell division cycle. The control coefficient
of reaction step x on RP is the percentage change in the fraction of the cell cycle
length at which RP occurs for a 1% change in the activity of x. If we had defined
the RP as an absolute time point, then the sum of control coefficients would add
up to -1 (as they do for the control on the cell division time).
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Figure 4.1: The reaction network scheme of the mammalian cell cycle
model. The network consists of 52 reactions which are grouped into 6 mod-
ules. A.) A central component of the model is the antagonism between Cyclin
B and Cdh1 (reactions 19, 20, 21 and 42). This antagonistic nature of the
cell cycle is found amongst all eukaryotes. B.) Included in the mammalian
cell cycle model are the early and delayed-response genes (ERG and DRG
respectively). In the scheme the steps responsible for ERG, DRG and Cy-
clin D synthesis are reactions 34, 39 and 41. Growth factors bind to specific
receptors found on the plasma membrane to subsequently stimulate an in-
tracellular signal-transduction pathway that activates ERGs. The ERGs then
activate DRGs and Cyclin D which set the cell division cycle in motion. C.)
The retinoblastoma protein (Rb) is a general inhibitor of E2F (a transcription
factor), and is distributed between an active, hypophosphorylated form (PP-
Rb) and an inactive form. The phosphorylation of Rb is induced by Cdk/cyclin
complexes. D.) P27, a Cyclin dependent kinase inhibitor in the G1 phase,
also binds to Cyclin A/Cdk2 (CYCA) and Cyclin E/Cdk2 (CYCE) dimers to
form inactive trimers (CA and CE respectively, these steps occur within the
Cyclin - Cyclin dependent kinase inhibitor module). Reactions are indicated
by number; white number on black background denote reactions that are al-
losterically regulated, reactions encircled with a dotted line are dependent
on ribosome activity (eps factor in model reactions), see the specific rate
equation for each of the reaction steps in Appendix 1.
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Figure 4.2: Time course of the mammalian cell division cycle. A time
integration for 30 h is shown for six of the intermediates of the system. The
G1, S/G2 and M-phases for one cell cycle are indicated in the graph. The
restriction point (RP) is also depicted in the G1-phase. It should be noted
that in contrast to other switch points in the model the RP is not a hard coded
event, i.e. it is not an explicit function, but rather an emergent property of
the model, and it is empirically defined as the last time point where, upon
cycloheximide (CHX) treatment, the cell would not finish the division cycle it
started with. The CHX treatment was mimicked in the model by reducing the
translation efficiency of the ribosomes ( or Eps(t)), a parameter found in all
synthesis steps of the model, from 1.0 to 0.5. This definition was taken from
the original publication in which the model was described56.
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The four steps delaying the restriction point the most (i.e. with the highest
positive control values) are (i) the breakdown reaction of the delayed response
genes (Reaction 2, CRP2 ∼ 7), (ii) the step involved in proteolysis of Cyclin D in
the Cyclin D:p27 complex, releasing the cyclin dependent kinase inhibitor (p27),
(Reaction 3, CRP3 ∼ 5), (iii) the phosphatase reaction responsible for the dephos-
phorylation of retinoblastoma (Reaction 44, CRP44 ∼ 5) and (iv) the reaction step
responsible for the synthesis of p27 (Reaction 40, CRP40 ∼ 3).
The steps advancing the restriction point the most (i.e. with the highest neg-
ative control values) are (i) the synthesis reactions of the delayed response genes
(DRGs) and Cyclin D (Reactions 41 and 39, CRP41 ∼ −7 and CRP39 ∼ −5), (ii)
the cyclin mediated phosphorylation of retinoblastoma to release it from the
retinoblastoma:E2F complex yielding free E2F (Reaction 29, CRP29 ∼ −4) and (iii)
the reaction responsible for the production of Cyclin E (Reaction 38, CRP38 ∼ −3).
In a recent publication Yao et al. illustrated with a core model and ex-
perimental data of individual gene expression levels that the interplay between
retinoblastoma and E2F creates a bistable switch that probably regulates the re-
striction point84. Although p27 was not modeled explicitly in this core model (its
importance was stated in the text), there is still a strong similarity between the
reactions that control RP, together with the feedback loops from Cyclin D and
Cyclin E, in our model and the reactions involved in the bistable switch in the
Yao model. Thus, according to our analysis of the model of Novak and Tyson,
taken together with the summation theorem, the interplay between retinoblas-
toma and E2F that creates a bistable switch indeed has a strong effect on the
restriction point, but with a net positive control (i.e. advancing the restriction
point) which is countered by the reactions affecting p27 (i.e. delaying the re-
striction point).
To identify the mechanism underlying the high control coefficients of these
steps for RP, we first analyzed which molecular species showed the same con-
trol pattern as was observed for the restriction point. A strong correlation be-
tween the control on RP and the concentration control coefficients of species
directly involved in the molecular machinery governing the restriction point is
to be expected. To test this we plotted the concentration control coefficients for
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the model variables against the RP control for each of the reaction steps (Fig-
ure 4.4). For 9 of the 23 molecular species a strong correlation was observed,
with some species showing a positive correlation while others have a negative
correlation and that all species have a different slope in the correlation plots (note
that the y-axes between the plots differ). The 9 variables that showed a strong
correlation were Cyclin A, Cyclin D, Cyclin E, Cyclin E:p27 complex, p27, hy-
perphosphorylated retinoblastoma, E2F transcription factor, unphosphorylated
retinoblastoma and unphosphorylated retinoblastoma bound to E2F transcrip-
tion factor. All of these species either reside in the early and delayed response
genes module, in the cyclin - cyclin dependent kinase inhibitor module or the
retinoblastoma - E2F transcription factor module (see Figure 4.1 modules B, C
and D). These are the same three modules that also contain the aforementioned
eight steps with the highest absolute CRPi values.
A sensitivity analysis for the system variables was made at the restriction
point. For this we initialized all variables in the model at their concentrations
at RP, except for one variable to which we made a small perturbation. A subse-
quent simulation was analyzed with respect to cell cycle completion, i.e. testing
whether the perturbation made to the one variable could prevent RP. The per-
turbation we made to the variable was to change its value to a value it had just
before RP (i.e. followed its integration path back in time). In this way we deter-
mined the minimal time period that a variable must be regressed from RP along
its time integration in order to stall the cell cycle progression. From this analysis
it was evident that the RP was most sensitive for changes made to the Cyclin
E/Cdk2:p27 complex; changing its value to the value it had 0.04 s before the
RP resulted in the cells entering quiescence. The species which values needed
to be regressed 0.5 s or less to prevent RP are listed in Table 4.1, each of these
variables also showed a good correlation in Figure 4.4.
The six metabolites for which RP showed a high sensitivity each had a dif-
ferent gradient in the correlation plots (Figure 4.4); for some intermediates the
correlation was positive, for others negative and each had a different slope. The
correlations observed in Figure 4.4 suggest that several of the intermediates also
correlate with one another (independent of which reaction is perturbed). Such
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Figure 4.4: Correlation Plots for Concentration Control coefficients and
RP control. Species that showed a good correlation between their concen-
tration control coefficients and restriction point control coefficients are shown
in the top nine figures. To illustrate the contrast, we also show plots for three
species that did not show a good correlation in the bottom figures. Cyclin
E/Cdk2:p27 is abbreviated to CE on the axis label. See text for further de-
tails.
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Table 4.1: Species dependent regression time necessary for cells to en-
ter quiescence. The six molecular intermediates for which the RP showed
the highest sensitivity were each regressed in time (while initializing all other
intermediates at their RP concentrations) until, upon subsequent simulation
the cells enter quiescence. This minimal time that a specie must be re-
gressed to prevent RP is listed as Regression time in the table. Also the
RP concentration and the percentage change in concentration of the inter-
mediate concentration at the regression time point compared to the RP are
given. (AU=arbitrary units)
Specie Regression time % change in concentration Concentration at RP
(s) (AU)
CE 0.04 0.0003 0.48
CA 0.18 0.004 0.02
P27 0.22 -0.001 0.86
E2F 0.22 0.004 0.35
CYCE 0.47 0.007 0.01
Rb 0.54 -0.009 0.27
covariances between intermediates make it difficult to asses a causal relation.
The RP showed the highest sensitivity for changes in the concentration of Cy-
clin E/Cdk2:p27 (Table 4.1); all of the other species needed to be perturbed
more, either in terms of time regression or in terms of percentage change in their
concentrations. This high sensitivity indicates that this intermediate is important
for the regulation of RP, and we tested whether the difference in slopes in the
correlation plots could be related to co-correlations between the intermediates
and Cyclin E/Cdk2:p27.
For this we first determined the co-control coefficients of Cyclin E/Cdk2:p27
with the 9 intermediates that showed a good correlation in Figure 4.4. A co-
control coefficient is defined as the ratio of two concentration control coefficients
and quantifies the correlation between the two intermediates upon a small pertur-
bation of a reaction step42. Interestingly, the values for the co-control coefficients
were largely independent on the reaction step that was perturbed, i.e. two inter-
mediates would co-vary, independent of which step was perturbed. Thus, the
co-control coefficients of the model species with the Cyclin E/Cdk2:p27 com-
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plex quantify the extent that these species co-vary with the complex. For ex-
ample, Cyclin E/Cdk2 (CYCE) and Cyclin E/Cdk2:p27 (CE) showed a positive
co-variation, with a co-control coefficient iOCYCECE of 0.53, indicating that changes
in the concentration of CE were correlated with roughly half the concentration
change in CYCE. In contrast CE is negatively correlated with p27Kip1, i.e. if
the one goes up the other goes down, quantitatively expressed in a co-control
coefficient, iOp27CE of -1.2.
Subsequently, we calculated the ratio of the gradients in the correlation plots
(Figure 4.4) for the intermediates and for Cyclin E/Cdk2:p27. For each of the
intermediates the ratio of its gradient in the correlation plot and the gradient
of Cyclin E/Cdk2:p27, was close to the value of the co-control coefficient of
the intermediate with Cyclin E/Cdk2:p27. For example the gradient ratio for
Cyclin E/Cdk2 and Cyclin E/Cdk2:p27 equals 0.49 and for p27Kip1 and Cyclin
E/Cdk2:p27 the ratio equals -1.1 (these values are close to the respective co-
control coefficients 0.53 and -1.2 as calculated above). This result is in agree-
ment with the hypothesis that the correlations observed in Figure 4.4, between
changes in system intermediate concentrations and RP, can be accounted for by
co-correlations of those intermediates with Cyclin E/Cdk2:p27.
The observation that Cyclin E/Cdk2:p27 needed to be regressed for the short-
est time period (Table 4.1) indicated that this molecular specie on its own could
prevent RP. Regressing any of the other species further back in time could po-
tentially effect RP indirectly via Cyclin E/Cdk2:p27. We further tested this by
analyzing the effect on Cyclin E/Cdk2:p27 concentration upon perturbing each
of the other variables to which the RP showed a high sensitivity. Indeed, as can
be seen in Figure 4.5a, changing any of these variables to such an extent that
they interfered with the RP did lead to a change in Cyclin E/Cdk2:p27. Each
of the curves in Figure 4.5a is the result of a separate time simulation for the
Cyclin E/Cdk2:p27 concentration upon a perturbation of the indicated (red cir-
cle) model variable. The wt curve is the reference curve where no perturbation
was made. The time point (x-axis value) corresponding with the red symbols
indicates RP. From the figure it can be seen that the shift brought about to the
RP was in very good agreement with the extent that the concentration of Cyclin
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E/Cdk2:p27 was effected by the perturbation; for most metabolite perturbations
RP was shifted to the time point where the Cyclin E/Cdk2:p27 complex reached
a critical concentration. Since a causal relation between Cyclin E/Cdk2:p27 con-
centration and the RP would necessitate that for each perturbation of the complex
the RP must shift accordingly, we perturbed all reaction steps with a high control
on RP and plotted the occurrence of RP together with the trajectory for Cyclin
E/Cdk2:p27 (Figure 4.5b). The reactions that were perturbed for each of the
curves in the figure are indicated by number (corresponding with the numbers in
Figure 4.1). Again a very good correlation, in excellent agreement with the shift
in RP upon metabolite perturbations was observed for the reaction perturbations.
The correlation plots along with the sensitivity analysis are indicative of a causal
relation between the Cyclin E/Cdk2:p27 concentration and RP; independent of
the type of perturbation made, a critical Cyclin E/Cdk2:p27 concentration must
be reached for RP transition.
4.3.1 RP control in Cancer Cells
Deregulation of the restriction point is implicated in almost all tumor cells and
it has been suggested that regulation of the restriction point is essential to pre-
vent cells from becoming cancerous58. We thus investigated whether the species
shown by our analysis to alter the restriction point were indeed implicated in ma-
lignancies in mammals. Comparing phenotypic observations of tumor cells with
our analysis results, we indeed observed that changes to the cells lines that would
lead to an increased concentration of Cyclin E/Cdk2:p27 concentration, such as
cyclin E overexpression66,65,37,73 and p27Kip1 downregulation59,26,28,37,73 yielded
uncontrolled tumour proliferation in a wide range of human tissues. Furthermore
it was observed that in aggressive stomach, prostate, breast, lung and pituitary
cancers, p27Kip1 levels were low, either due to degradation or due to translocation
to the cytoplasm86,16. These observations are in agreement with our co-control
analysis; the co-control coefficients, iOCYCECE = 0.53 and
iOp27CE = -1.2 quantify
a strong positive correlation between cyclin E and Cyclin E/Cdk2:p27 and a
strong negative correlation between p27 and Cyclin E/Cdk2:p27, where these
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Figure 4.5: Control of the restriction point via the Cyclin E/Cdk2:p27.
For each of the six species towards which RP showed a high sensitivity (see
Table 4.1) a perturbation was made to its concentration such that it would
affect RP, while all other variables where initialized with their RP concen-
trations. The results of the subsequent time integrations, following Cyclin
E/Cdk2:p27 concentration and the occurrence of RP, are plotted in (a), with
the points in the graphs denoting the time point of RP (x-axis) and the con-
centration of Cyclin E/Cdk2:p27 (y-axis). For each simulation the perturbed
variable is indicated. In (b) the results of similar integrations are shown, now
after perturbation of the 8 reactions that had a high RP control.
co-control coefficients are largely independent on which step is perturbed. These
observations and model analyses lead us to hypothesize that RP is advanced in
Chapter 4. Restriction Point Control of the Mammalian Cell Cycle 46
cancer cell lines due to increased concentration of Cyclin E/Cdk2:p27.
4.4 Conclusions
In cancer cells restriction point control appears to be completely absent. On the
basis of an extensive analysis of a detailed kinetic model, we hypothesize that
such a shift of the RP to a much earlier point in the cell cycle might be caused
by an increased concentration in the Cyclin E/Cdk2:p27 complex concentration.
We showed that a perturbation of Cyclin E/Cdk2:p27 on its own was sufficient
to shift the RP. In addition we showed that in perturbations of any of the reaction
steps, the effect on RP could always be explained via a change in the Cyclin
E/Cdk2:p27 concentration, leading us to propose that RP control by the reaction
steps works via the Cyclin E/Cdk2:p27 complex. The method that we have used
to quantify the control of a reaction step on any of the systems variables can
be used to identify the reaction steps that would have the biggest effect on the
Cyclin E/Cdk2:p27 concentration and therewith would shift RP most strongly.
Furthermore, in principle the method provides with a tool to calculate the extent
with which a reaction must be perturbed to shift RP back to its normal position.
The precision of such predictions would of course be dependent on the quality
of the mathematical model, but the analysis methods we propose here can be
applied generically and are not model specific. The strength of these methods
were illustrated for the analysis of RP control and the results clearly indicate that
the control of RP runs mostly via Cyclin E/Cdk2:p27. An important implication
would be that it should be possible to shift RP in cancer cells back to its normal
point via perturbations of steps that effect the Cyclin E/Cdk2:p27 concentration.
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4.6 Appendix 1
Table 4.2: Mammalian cell cycle model56 kinetics:
Reaction
number
Rate equations
1 v(1) = k16 · ERG(t)
2 v(2) = k18 · DRG(t)
3 v(3) = K10 · CD(t)
4 v(4) = K10 · CYCD(t)
5 v(5) = K25 · P27(t) · CYCE(t)
6 v(6) = K25 · P27(t) · CYCA(t)
7 v(7) = k24 · CYCD(t) · P27(t)
8 v(8) = k24r · CD(t)
9 v(9) = K30 · Cdc20(t) · CYCA(t)
10 v(10) = K30 · Cdc20(t) · CA(t)
11 v(11) = K25R · CE(t)
12 v(12) = K25R · CA(t)
13 v(13) = V8 · CE(t)
14 v(14) = V8 · CYCE(t)
15 v(15) = V6 · P27(t)
16 v(16) = V6 · CE(t)
17 v(17) = V6 · CD(t)
18 v(18) = V6 · CA(t)
19 v(19) = V2 · CYCB(t)
20 v(20) = (K3a+K3·Cdc20(t))(1−Cdh1(t))J3−Cdh1(t)+1
21 v(21) = V4·Cdh1(t)J4+Cdh1(t)
22 v(22) = K34 · PPX(t)
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23 v(23) = K31·CYCB(t)(1−IEP(t))J31−IEP(t)+1
24 v(24) = K32·PPX(t)·IEP(t)J32+IEP(t)
25 v(25) = K12 · Cdc20T(t)
26 v(26) = K13·IEP(t)(Cdc20T(t)−Cdc20(t))J13−Cdc20(t)+Cdc20T(t)
27 v(27) = K14·Cdc20(t)J14+Cdc20(t)
28 v(28) = K12 · Cdc20(t)
29 v(29) = E2F-Rb(t)(K20(CYCDT · LD + LA ·CYCA(t) +
LB · CYCB(t) + LE · CYCE(t)))
30 v(30) = P-E2F-Rb(t)(K20(CYCDT·LD+LA·CYCA(t)+
LB · CYCB(t) + LE · CYCE(t)))
31 v(31) = K27 · MASS(t) ·
If
[
Rb(t)+E2F-Rb(t)+P-E2F-Rb(t)
PP-Rb(t)+Rb(t)+E2F-Rb(t)+P-E2F-Rb(t) > 0.8, 0, 1
]
32 v(32) = K28 · GM(t)
33 v(33) = eps(t) ·MU · GM(t)
34 v(34) = eps(t)·k15(
DRG(t)
J15
)2
+1
35 v(35) = eps(t)(K11a + K11 · CYCB(t))
36 v(36) = eps(t) · K29 · E2F(t) ·MASS(t)
37 v(37) = eps(t) · K33
38 v(38) = eps(t)(K7a + K7 · E2F(t))
39 v(39) = eps(t) · K9 · DRG(t)
40 v(40) = eps(t) · K5
41 v(41) = eps(t) ·
(
k17
(
DRG(t)
J17
)2(
DRG(t)
J17
)2
+1
+ k17a · ERG(t)
)
42 v(42) = eps(t) ·
(
K1·
(
CYCB(t)
J1
)2(
CYCB(t)
J1
)2
+1
+ K1a
)
43 v(43) = Rb(t)(K20(CYCDT · LD + LA · CYCA(t) + LB ·
CYCB(t) + LE · CYCE(t)))
44 v(44) = PP-Rb(t)(K19a(PP1T − PP1A) + K19 · PP1A)
45 v(45) = E2F-Rb(t) · K26R
46 v(46) = E2F(t)(K23a + K23(CYCA(t) + CYCB(t)))
47 v(47) = P-E2F(t) · K22
48 v(48) = E2F(t) · Rb(t) · K26
49 v(49) = P-E2F-Rb(t) · K26R
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50 v(50) = Rb(t) · P-E2F(t) · K26
51 v(51) = P-E2F-Rb(t) · K22
52 v(52) = E2F-Rb(t)(K23a + K23(CYCA(t) + CYCB(t)))
Model parameters in56:
k15=0.025; k16=0.025; J15=0.1; k17a=0.035; k17=1.; J17=0.3; k18=1.; K9=0.25;
K10=0.5; k24=100.; k24r=1.; K7a=0.;
K7=0.06; K8a=0.01; K8=0.2; K25=100.; K25R=1.; J8=0.1; YE=1.; YB=0.05; K29=0.005;
K30=2.; K1a=0.01; K1=0.06; J1=0.1; K2a=0.005; K2=2.; K2aa=0.1; K5=2.; K6a=1.;
K6=10.; HE=0.5; HB=1.; HA=0.5; LD=3.3; LE=5.; LB=5.; LA=3.;
K20=1.; K19a=0.; K19=2.; K21=1.; PP1T=1.; FE=25.; FB=2.; K3a=0.75; K3=14.;
J3=0.01; J4=0.01; K4=4.; GE=0.; GB=1.; GA=0.3; K33=0.005; K34=0.005; K31=0.07;
K32=0.18; J31=0.01; J32=0.01; K11a=0.; K11=0.15; K12=0.15; K13=0.5;
K14=0.25; J13=0.005; J14=0.005; K22=0.1; K23a=0.0005; K23=0.1; K26=1000.;
K26R=20.; K27=0.02; K28=0.02; MU=0.0061;
Definitions and steady state relations:
PP1A = PP1TK21·(FE·(CYCA(t)+CYCE(t))+FB·CYCB(t))+1
V2 = K2aa · Cdc20(t) + K2a · (1 − Cdh1(t)) + K2 · Cdh1(t)
V4 = K4 · (GA · CYCA(t) + GB · CYCB(t) + GE · CYCE(t))
V6 = K6a + K6 · (HA · CYCA(t) + HB · CYCB(t) + HE · CYCE(t))
V8 = (YE·(CYCA(t)+CYCE(t))+YB·CYCB(t))·K8CYCET+J8 + K8a
CYCET = CE(t) + CYCE(t)
CYCDT = CD(t) + CYCD(t)
CYCAT = CA(t) + CYCA(t)
P27T = CA(t) + CD(t) + CE(t) + P27(t)
EPS(t) = 1
Chapter 5
Comparing G1/S Transition
Control in yeast and mammalian
cell models
5.1 Introduction
The eukaryotic cell cycle can be divided into four phases: G1, S, G2 and M, which are
separated by clearly defined transitions, e.g. DNA replication starts at the G1/S transi-
tion and the G2/M transition is market by the condensation of chromosomes into visible
structures. The transitions from the gap phases (G1/S and G2/M) are associated with
so-called checkpoints, where a condition must be fulfilled for the transition to occur. We
here focus on the G1/S transition, deregulation of which has been shown to be associated
with many disease states, notably cancer84,58.
Two checkpoints have been proposed to be linked to the G1/S transition: 1) a mass
assessment point, referred to as START in yeast and 2) the restriction point (coined by
Arthur Pardee58), where mammalian cells evaluate external growth factor signals (see
Chapter 4). Zetterberg and Larsson showed that cells in the G1 phase, when deprived of
growth factors or pulse treated with cycloheximide, either suffer an immediate and long
delay, or finish the current cell division cycle, dependent on whether the perturbation was
made before or after the restriction point85. The restriction point is an important switch
50
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point where cells enter either the quiescent (G0) phase or proliferate, and it appears to
be strongly affected in cancer cells.
In yeast, fairly strong evidence exists for a mass assessment checkpoint for the G1/S
transition. A proposed mechanism via which cells sense their mass is the accumulation
of a ‘sizer’ protein in the nucleus83,64. Assuming a proportionality between cell volume
and the amount of a given protein, a correlation will exist between the nuclear concen-
tration of that protein and the cell volume, if the protein is transported into the nucleus
(which volume is relatively constant). In yeast, Futcher showed that Cln3 (a G1 cyclin)
accumulates at a rate proportional to the cytosolic volume79. Thus, a mass assessment
checkpoint could function via sensing the concentration of a ‘sizer’ protein in the nu-
cleus. The accumulation of the nuclear concentration of the G1 cyclin above a certain
threshold level makes a transition to the S phase possible35,79. Futcher has reported on
experiments in strong agreement with this mechanism by showing that a 10% increase
in nucleus size led to an almost similar increase in critical size79.
In contrast, the experimental evidence for the existence of such a mass assessment
point in mammalian cells is less convincing. Experiments from Zetterberg are indicative
for the existence of another checkpoint in addition to the restriction point. He found an
inverse proportionality (See Figure 5.1) between cell mass at the start of the G1 phase
and the relative increase in mass, when this increase was measured over the total G1
phase, but not when measured up until the restriction point79. In addition, Killander and
Zetterberg have shown in mouse fibroblasts, that cells with a smaller mass at the start
of the cell cycle have a longer G1 phase resulting in roughly the same mass for all cells
entering the S phase50. Even though these result may seem compelling, the existence
of a mass assessment checkpoint is still a matter of debate. For instance, Conlon and
Raff17 proposed that for size homeostasis to occur in mammalian cells there need not be
any mass assessment checkpoint but this has been contested by Cooper20 and Sveiczer
et al.72. This issue was again discussed in the July 2009 issue of Science77,25.
Although the restriction point and mass assessment point are distinct in mechanism,
it is not so easy to experimentally distinguish between these checkpoints. It is much eas-
ier to test the proposed hypotheses with respect to the checkpoints for the G1/S phase in
mathematical models, as these models make it possible to make specific perturbations
and analyze their effects on both cell mass and the G1/S transition point. Cell cycle
models have been constructed for over 20 years; many of these model are core mod-
els, which capture particular behavior of a system in a minimal description. However,
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Figure 5.1: Zetterberg Experiment. Zetterberg found that cells with a small
postmitotic mass have a more pronounces percentage mass increase during
the G1 phase when compared with a larger mass at the beginning of the cell
division cycle.
by adding more detail to these models and by fitting them to experimental data, these
models have become predictive, for instance in predicting mutant behavior14. We have
selected cell cycle models for mammalian cells and yeast and performed a comparative
analysis on these models to test whether a constant mass is maintained at the G1/S tran-
sition point, irrespective of model perturbation. In this chapter we first introduce the
selected models and define control on the transition point in the framework of metabolic
control analysis. Then we compare the control distribution in the cell cycle models on
the G1/S transition point. Subsequently we move to the control of a constant mass at the
G1/S transition point and finally we discuss whether a consensus exist in these models
with respect to the above described debate.
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5.2 The models
Cell cycle models for budding yeast and mammalian cells, in which the Cdh1/APC com-
plex was explicitly modeled and which contained a mass (or volume) component, were
selected from the literature. These models (which included a number of core models),
varied strongly in the level of detail in which the cell cycle was described, and we iden-
tified overlapping modules between the models to construct a cell cycle network that
we could use to compare the models. After having standardized the names for variable
species* and reactions for the respective models, we could construct a cell cycle net-
work containing all the reactions and species that were used in the selected models (see
Figure 5.2).
We have included a conversion table for acronyms of variables as used in the models
(and in this chapter) to the acronyms occurring widely in the literature (Table 5.1). Note
that often implicit assumptions are made in the models, for instance clb2 is the only non-
complexed B type cyclin that is modeled explicitly in budding yeast. Thus, whereas 6
type B cyclins are known to exist in budding yeast, we only use clb2 as a non-complexed
species (see Table 5.1 and Figure 5.2), reflecting the assumption that all other B type
cyclins are complexed with their respective kinases (and listed in capitals, e.g. CLB5).
*There is no consistent use of acronyms in the literature, and different names are used for
the same proteins in different organisms, making it hard to make comparisons between models
and between species. The names of variable species as they occur in the original publications
are tabulated in Appendix 1 (see Tables 5.2, 5.3 and 5.4 in Section 5.8).
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Table 5.1: Conversion table for names of proteins and their complexes
Proteins and complexes are listed with the names used in our integrated cell
cycle scheme (first column) and with the names to which they are referred to
in the literature and models for budding yeast, fission yeast, mammalian cell.
Synonym list
Specie Budding Yeast Fission Yeast Mammalian cell
clb2 Clb1-6 Cdc13 Cyclin B
cdk Cdc28 Cdc2 Cdk1
CLB2 Cdc28/Clb1,2 Cdc2/Cdc13 Cdk1/CycB
CLN2 Starter Kinase (SK), Cln1,2/Cdc28 - CycE/Cdk2
SIC1 Sic1 Rum1 p27Kip1, Kip1
CLB5 Clb5,6/Cdc28 Cig2/Cdc2 CycA/Cdk1,2
CYCD Cln3/Cdc28 Cdc2/Puc1 CycD/Cdk4,6
E2F SBF, MBF, Swi4/Swi6, Mbp1/Swi6 Cdc10/Res1 E2F
CDC14 Cdc14 Clp1/Flp1 hCdc14
CDH1A Cdh1 Ste9 Cdh1, hCdh1
CDC20A Cdc20 Slp1 p55cdc, p55cdc
SWE1 Swe1 Wee1 hWee1
MIH1 Mih1 Cdc25 Cdc25c
5.2.1 Budding yeast cell cycle models
Four cell cycle models were selected for the yeast S. cerevisiae76,21,15,14. All the
budding yeast models contained the following species: CDC20, active CDH1A,
CLB2, CLN2, SIC1 and MASS, around which we defined the modules for our
comparative analysis.
The Tyson model76 has 8 variables (proteins and their complexes) and is an
extension of a core model also included in our comparative analysis. The core
model illustrates the antagonistic interactions between cyclin-dependent kinases
and the anaphase promoting complex that causes a cell to progress from the G1
to the S-G2-M state. This core model was extended by including a cyclin depen-
dent kinase inhibitor and a starter kinase (see Figure 5.3), to give a simplified
description of the cell division cycle in budding yeast.
The Csikasz model, (Figure 5.4) consists of 14 ordinary differential equa-
tions (ODEs) with 35 reactions and was constructed by including budding yeast
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Figure 5.3: Budding yeast cell cycle model: Tyson
specific parameter values in a generic model for the eukaryotic cell cycle21.
This generic model can be used to construct species-specific models for bud-
ding yeast, fission yeast, frog oocytes and mammalian cells by selecting, from
the generic eukaryotic cell cycle model, the appropriate modules and using the
unique parameter set for the specific organism.
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Figure 5.4: Budding yeast cell cycle model: Csikasz
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Chen et al. constructed two kinetic models of budding yeast published four
years apart. The first model (see Figure 5.5), published in 200015 consisting of
13 ODEs and 30 system processes, was constructed to describe the molecular
events controlling "Start" and "Finish" in wild type cells and 50 mutants. As
new information about the M-to-G1 transition ("exit from mitosis") of budding
yeast became available, Chen et al. published a kinetic model of budding yeast
in 200414 that could describe wild type cells and 120 mutants cells (of the 131
mutants known at the time). The latter model (see Figure 5.6) consists of 36
ODEs with 95 system processes and 2 events.
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Figure 5.5: Budding yeast cell cycle model: Chen
5.2.2 Mammalian cell cycle models
Three mammalian cell cycle models were included in our comparative analy-
sis21,56,18. The Csikasz2 model depicted in Figure 5.7 was constructed in a sim-
ilar manner as the budding yeast cell cycle model from the same publication21,
but now mammalian cell cycle modules and specie-specific parameters were in-
cluded in the generic eukaryotic cell cycle model. The model consists of 12
ODEs with 29 system processes and one event.
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Figure 5.6: Budding yeast cell cycle model: Chen2
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Figure 5.7: Mammalian cell cycle model: Csikasz2
The Novak model was constructed on the basis of a budding yeast model to
which auxiliary processes found in mammalian cells, such as a module describ-
ing the interaction of retinoblastoma protein and E2F transcription factor as well
as a growth factor sensing module were added56. The model consists of a system
of 18 ODEs with 40 system processes and 1 event (Figure 5.8). The Conradie
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model (Figure 5.9) consists of 23 ODEs with 50 reactions and was constructed
on the basis of the Novak model. The algebraic equations in the original model,
used for the description of the regulatory mechanism of phosphorylation of the
retinoblastoma protein (Rb) and its inhibitory effect on the E2F transcriptional
activation protein, were converted into ODEs (see Chapter 4).
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Figure 5.8: Mammalian cell cycle model: Novak
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Figure 5.9: Mammalian cell cycle model: Conradie
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5.2.3 Core cell cycle models
Three core models were included in our comparative analysis,69,71,76. Two of
these models were very different from the other models in our study and the
third one was a core model from the Tyson group.
The Srividhya model69 is a general eukaryotic cell cycle model, consisting
of 7 ODEs and 13 processes, with a delay equation for the description of the
activation of the APC by clb2, acting as a spindle checkpoint.
The Surovstev model71 is build within a whole cell modeling framework.
The cell cycle part of the model consisted of 5 ODEs and 13 processes. The
model is build from a physico-chemical perspective with the cytosolic volume
and the membrane surface modeled explicitly.
In the Tyson2 model76, focus is placed on the antagonistic interaction be-
tween the cyclin dependent kinases and the APC. The model consists of 6 ODEs
and 12 processes.
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5.3 Definition and position of the G1/S transition
point
The G1/S transition point is defined by the start of DNA synthesis, which coin-
cides with the increase in the concentration of Cyclins/Cdk and a decrease in the
CDH1 concentration. For our analyses we have used the point where the CDH1
concentration has dropped halfway from its maximum value (in the G1 phase)
to its minimum value (in the S phase) to quantify the time point where the G1/S
transition occurs.
For the non core models the G1/S transition point occurred at positions in the
cell division cycle, varying between approximately 30% and 70% of the com-
plete cell cycle (Figure 5.10). All of the models showed a switch type behavior
where the CDH1 concentration drops rapidly from its maximal to its minimal
value.
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Figure 5.10: Cdh1 concentration for budding yeast (blue) and mam-
malian cell (red) models as the cell progresses through one division
cycle. The Novak and Conradie models followed the same trajectory.
After defining the G1/S transition point, and noting that the location of the
point differs markedly between the different models we analyzed which of the
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reactions in the models were important for the positioning of the transition point
using metabolic control analysis.
5.4 Control of the G1/S transition
To compare a set of models we identified the proteins and their complexes that
were represented in all the models within the set. Subsequently, for each of
these common species we grouped the reactions that either formed or degraded
that specie in a module. These modules give the structural basis on which
we compared the models. For instance in all the budding yeast models CLB2
was represented; in the simplest model there were only 2 reactions that syn-
thesized/degraded CLB2, while in the most detailed budding yeast model there
were 8 reactions in that module. When we compare control distributions in the
different models, we compare the control of these modules. This modular ap-
proach makes it possible to compare models that differ greatly in detail. We
first determined the control of the reactions modules on the position of the G1/S
transition.
5.4.1 G1/S transition control in budding yeast
As a first analysis we compared several budding yeast cell cycle models to de-
termine how the respective cell cycle reactions control the G1/S transition. As
explained in Section 5.4, we first defined the modules occurring in all budding
yeast models: these were the reactions producing and consuming active Cdc20A,
inactive Cdc20, active Cdh1, CLB2, CLN2 and SIC1 as well as the step describ-
ing MASS accumulation. Subsequently we determined the control of each of the
reactions by making small perturbations and analyzing its effect on the position
of the G1/S transition point. For more details on this method see Section 2.3.
The control of the reactions in each of the modules were added together, giving
the overall control exerted by this module on the positioning of the G1/S transi-
tion point (where the transition point is expressed as the length of the G1 phase
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divided by the total length of the cell cycle). In Figure 5.11, we have shown the
control of the seven modules on the G1 fraction of the cell cycle, for the four
budding yeast models.
(a) Csikasz (b) Chen
(c) Chen2 (d) Tyson
Figure 5.11: Control on the length of the G1 phase as a fraction of the
cell cycle for the budding yeast models The control on the G1 phase frac-
tion by the modules of the following variable species: Cdc20A (1), Cdc20I
(2), Cdh1A (3), CLB2 (4), CLN2 (5), MASS (6), SIC1 (7), is shown for the
four budding yeast cell cycle models.
The control distribution over the seven modules is strikingly similar, with
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the majority of the control residing in two of the modules, the MASS and CLB2
modules, with most of the other modules having only a small contribution to
the positioning of the G1/S transition point. A positive control (leading to an
increasing in the length of the G1 phase relative to the total cell cycle length) was
exerted by the Cdc20I, and CLB2 modules in all models, whereas the CLN2, and
MASS modules had a negative control on the relative G1 phase length.
The control coefficients are not just a quantification of the sensitivity of the
system for perturbations in reaction rates. As derived in Section 2.3, summation
theorems exist for the control coefficients of a system, and for the G1/S transition
point (expressed as the fractional length of the G1 phase to the total length) the
theorem states that the control coefficients should sum up to 0. Thus, by defini-
tion control on the G1/S transition point must be distributed over the system, re-
sulting in no net change in the transition point if al reactions were to be perturbed
simultaneously (with the same percentage change). Although our comparative
analysis does not necessarily include all reactions of the system (we focussed on
the reactions producing or degrading the common intermediates), we made sure
that our modules included the vast majority of the controlling reactions.
5.4.2 G1/S transition control in mammalian cells
Analogous to the definition of modules for the budding yeast models we defined
modules for the mammalian cell cycle models, grouping the reactions synthesiz-
ing or degrading the following common species: CA, Cdc20A, Cdc20I, Cdh1,
CLB2, CLB5, CLN2, CE, IEP, MASS, and SIC1. In Figure 5.12, we have shown
the control of the eleven modules on the G1 fraction of the cell cycle, for the four
budding yeast models.
Also for the mammalian models a strikingly similar distribution for G1/S
transition point control was observed for the different models. As was found for
the budding yeast models, in the mammalian cell cycle models, the MASS and
CLB2 modules have the highest control on the G1/S transition. Positive control
in all three models was observed for the Cdc20A, Cdc20I, CLB2, IEP, and SIC1
modules, while the CLB5, CLN2, CE and MASS modules had a negative control
Chapter 5. Yeast and Mammalian G1/S Transition Control 65
(a) Csikasz2 (b) Novak
(c) Conradie
Figure 5.12: Control on the length of the G1 phase as a fraction of the
cell cycle for the mammalian models The control on the G1 phase fraction
by the modules of the following variable species: CA (1), Cdc20A (2), Cdc20I
(3), Cdh1 (4), CLB2 (5), CLB5 (6), CLN2 (7), CE (8), IEP (9), MASS (10),
SIC1 (11), is shown for the three mammalian cell cycle models.
on the G1/S transition point.
The distribution of control over the different modules was very similar, not
only within the two groups of models, but also between the two groups, where
the most striking result was the high positive control for the CLB2 module and
the strong negative control for the MASS module. To test whether we could
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pin-point these distributions to a particular mechanism we analyzed several core
models, differing strongly from the detailed models.
5.4.3 G1/S transition control in core models
For the core models we chose the Srividhya model69, the Surovstev model71
and the Tyson2 model, a general cell cycle model by Tyson et al.76. For a brief
description of the models see Section 5.2.3. We defined three modules for the
core models, these include the reactions synthesizing/degrading the CDH1A,
CLB2 and MASS species. Note that in these core models some of the reactions
occur in more than one module.
In Figure 5.13 we show the G1/S transition control distribution over the mod-
ules for the three models. For the core models a positive control by the MASS
module was obtained, which implies that an increase in the MASS accumulation
or growth rate would lead to an increase in the percentage of time that a cell
would reside in the G1 phase. This is a very different control structure from that
obtained with the more realistic models.
(a) Srividhya (b) Surovstev (c) Tyson2
Figure 5.13: Control on the length of the G1 phase as a fraction of the
cell cycle for the core models The control on the G1 phase fraction by the
modules of the following variable species: CDH1A (1), CLB2 (2), MASS (3),
is shown for the three core cell cycle models.
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Tyson76 has illustrated how certain yeast like behavior could be obtained by
adding a starter kinase and a cyclin dependent kinase inhibitor in a core model.
We added these two reaction steps successively to a core model (Tyson2) and an-
alyzed the resulting models (respectively Tyson3, core model with starter kinase,
and Tyson, core model with both reactions added, equal to the model treated in
the detailed budding yeast models).
The simple addition of a single reaction, the starter kinase, changed the con-
trol structure that the reaction modules in the core model (Tyson2), exerts on
the time of G1/S transition point to that of the more detailed cell cycle models
(Figure 5.14a vs. Figure 5.14b). The further addition of a cyclin dependent ki-
nase inhibitor (CKI) did not markedly change the control exerted by the reaction
modules on the time of the G1/S transition point (Figure 5.14c vs. Figure 5.14b).
(a) Tyson2 (b) Tyson3 (c) Tyson
Figure 5.14: Comparison of cell cycle control in three tyson core mod-
els. The control on the G1 phase fraction by the modules of the following
variable species: CDH1A (1), CLB2 (2), MASS (3), is shown for the three
Tyson cell cycle models.
Thus far we have defined the G1/S transition point and determined the con-
trol on the positioning of the transition point in the total cell cycle. We now
move to the control of mass (cell size) at this transition point. First assessing the
robustness of constant cell mass at the transition point towards perturbation of
the reaction rates in the system.
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5.5 Control of mass at the G1/S transition point
A control coefficient quantifies the percentage change in a systems property
(such as the cell mass at the G1/S transition point) upon a 1 percent change
in a reaction rate. A such, it quantifies the robustness of the systems property
for changes in reaction rate perturbations; the smaller the control coefficient, the
larger the robustness of the property. Hans V. Westerhoff (personal communica-
tion) have used this characteristic of control coefficients to define the robustness
for systemic properties as R = 1/C. We have determined the control coefficients
of each reaction step on the size at the beginning of the cell division cycle and
at the G1/S transition. For each of the models, we calculated the average control
of all the reactions in a model on both the cell size at the beginning of the G1
phase and at the end of the G1 phase (Figure 5.15).
Figure 5.15 shows that the core models display a high average control coeffi-
cient value† on the size of cells at the G1/S transition point (average value±standard
deviation; Srividhya 2.6±5.4; Tyson2, 1.5±1.5; Surovstev 0.7±0.5) as well as
on the size of cells at the beginning of the cell division cycle. For the mam-
malian cell cycle model intermediate values for the control coefficients were ob-
tained (average value/standard deviation; Novak 1.3±1.5; Conradie 1.17±1.33;
Csikasz2 0.16±0.21), while the budding yeast models had the lowest control co-
efficients (average value/standard deviation; Chen 2 0.05±0.1; Chen 0.02±0.03;
Tyson 0.02±0.02; Csikasz 0.01±0.03). Furthermore, three of the detailed yeast
models (Csikasz, Chen and Tyson), not only showed a very high robustness for
mass at the G1/S transition point, which was much higher than the robustness
observed in any of the other models, but it was also higher than the robustness
on the mass at the beginning of the G1 phase. Thus, these latter models appear
to have a mechanism that corrects changes in cell size during the G1 phase; a
perturbation leading to an altered cell size at the beginning of the G1 phase, leads
to a much smaller change in cell size at the G1/S transition point.
Novak and Tyson76 have shown how a core model of the cell cycle can be
†The average control coefficient is calculated from the absolute values of the control coeffi-
cients
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Figure 5.15: Control of cell size at the beginning and at the end of the
G1 phase The average of the absolute value of the control coefficients for cell
size at the beginning of a cell division cycle is plotted against the average of
the absolute value of the control coefficients for cell size at the G1/S transition
point. Values for the budding yeast cell models (green dots), mammalian
cell cycle models (blue dots) and the three core models (yellow dots) are
shown. The y=x line is indicated to make the comparison of control on cell
size between the beginning and end of G1 phase easier.
converted into a simple yeast cell cycle model by the addition of two reaction
steps: a starter kinase and a cyclin dependent kinase inhibitor. We have analyzed
the effects of the two additions on the average of the absolute value of control
coefficients for cell size at the beginning and at the end of the G1 phase (Figure
5.16). The addition of the starter kinase to the core model makes the model more
stable with respect to cell size at both the beginning of the cell division cycle and
at the G1/S transition point (i.e. the model makes a shift to lower average control
on cell size at both time points). With the further addition of a cyclin dependent
kinase to the model, an increase in the average control on size at the beginning of
the cell division cycle is observed, together with a decrease in the average control
on the G1/S transition point - indicative of a mass “correction” mechanism in the
G1 phase.
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Figure 5.16: Control of cell size at the beginning and at the end of the
G1 phase for core Tyson models The average control coefficient for cell
size at the beginning of a cell division cycle is plotted against the average
control coefficient value for cell size at the G1/S transition point. Values are
shown for the core model (Tyson2)76, the core model with the addition of a
starter kinase (Tyson3), and the model with a subsequent addition of CKI
(Tyson).
5.6 Discussion and conclusions
In this chapter we focussed on control of the G1/S transition, paying special
attention to the robustness of cell size at the transition point for perturbation in
reaction rates. We used the generally applied definition for the G1/S transition;
a sharp decrease in Cdh1 and increase in cyclins/cdk complexes, to analyze a
series of mathematical models for the mammalian and budding yeast cell cycle.
For the analysis we used MCA to quantify the control of each of the reaction
steps in the model on the length of the G1 phase (expressed as a fraction of the
total cell cycle length). We subsequently defined modules of reactions around
the common species in the models, and control by these modules could be used
in a comparative analysis between the models. We linked the control on the
positioning of the G1/S transition point to control on mass at the G1/S transition
point to study the robustness of cell size at the end of the G1 phase.
A striking similarity was observed with respect to the control distribution
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for the detailed kinetic models, with a strong positive control by the Cyclin B
module and a negative control by the mass module. The underlying mechanisms
for the similarity for the control distribution could be related to the role of a
starter kinase, addition of which to a core model swapped the control of the mass
module from a positive control (as was typically observed in the core cell cycle
models) to a negative control (as observed in all detailed models). The control
by the mass module should be interpreted as a feedback loop; the extent in which
a perturbation of the mass module changes the mass, can be diminished if the
change in mass has an inverse effect on the length of the G1 phase (i.e. increase
in mass should lead to a decrease in length of G1 phase).
In a more direct analysis of the control of cell mass at the G1/S transition
point we observed an increase in the robustness (i.e. tendency of the cell mass at
the end of the G1 phase to be insensitive for perturbations) going from core mod-
els to detailed models for mammalian cells to detailed models of budding yeast
cell cycle models. However, for the core models and the mammalian models this
increased robustness was accompanied by an increased robustness in cell mass
at the beginning of the G1 phase, not pointing at a G1 phase specific mass cor-
rection mechanism. Only for the detailed budding yeast we observed a stronger
robustness for mass at the end of the G1 phase than robustness for mass at the
beginning of the G1 phase. Such a mass correction mechanism in the G1 phase
for budding yeast appears to be in strong agreement with the role that has been
attributed to the G1/S phase checkpoint in this organism.
To find the molecular basis for this correction mechanism would improve
our understanding of the mass assessment checkpoint, but the current models
do not contain sufficient molecular detail for such an analysis. This points to
the relativity of detail in the “detailed” kinetic models that we have analyzed.
Compared to the detail in which molecular interaction maps are described for
the cell cycles (see Figure 2.2)51, our current quantitative understanding of these
interactions is very limited, often we only have semi-quantitative information
(i.e. interaction is stimulatory or inhibitory), which precludes building ODE
type models at such a high level of detail. Thus, even in the models that we have
referred to as detailed, many of the reaction steps are combinations of a number
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of reactions. This does not invalidate the use of such models or the relevance
of analysis results for such models. For instance, by casting our analysis in the
modular MCA framework12,11,43,81 it is possible to relate control within a module
to the individual reactions in the module, if the module were to be opened up at
a later stage.
We first look at the molecular detail for the G1/S transition in the mod-
els that we have analyzed and then discuss some of the more detailed models
that have been constructed specifically for this transition. At the heart of the
G1/S transition lies the bistability between Cdh1/APC and CycB/Cdk complexes
brought about by their antagonistic interaction: CycB/Cdk inactivates Cdh1 and
Cdh1/APC attaches a destruction label to CycB/Cdk to induce proteolysis76. In
addition to this direct “negative” effect of CycB/Cdk on Cdh1/APC, the com-
plex also has a delayed “positive” effect via the activation of Cdc20 which in its
turn stimulates the synthesis of Cdh1. The effect of growth on this bistability
is incorporated in the core tyson model (Tyson2) by adding a mass term to the
rate equations for the reactions that are affected by CycB/Cdk. This is under the
assumption that CycB concentration in the nucleus (where CycB is active and
which concentration is not modeled explicit in the model) increases as cell mass
increase. This assumption is justified by experiments in which it was shown that
Cln3p, a yeast G1 cyclin accumulates at a rate that is determined by the cytosolic
volume79,35. As the cytosol increases in size, more Cln3p accumulates, but the
size of the nucleus stays relatively constant, leading to a higher nuclear Cln3p
concentration.
In the core models, the effect of a growth rate increase will result in either
a delay or advance of the bistable switch between Cdh1/APC and CycB/Cdk,
depending on whether the “positive” or the “negative” effect of the CycB/Cdk
loop is stronger. From the control analysis results on the G1/S transition of the
Tyson2 core model, it can be seen that an increase in growth rate leads to a
delay in the G1/S transition (mass module has a positive control on G1 phase
length (see Figure 5.13c). This shows that the “positive” effect of CycB/Cdk
is stronger than it “negative” effect. When the Tyson2 core model is extended
to include a starter kinase (Cln2) this changes the positive control by the mass
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module into a negative control. The starter kinase is an activator of the Cdh1
inactivation rate and lowering of the Cdh1 levels apparently makes the bistable
switch more sensitive to the direct “negative” effect of CycB/Cdk, leading to the
G1/S transition point to be advanced (i.e. take place earlier). When considering
the rate equations for the starter kinase (Cln2) in both the budding yeast and
mammalian cell models, it should be noted that models that appear more robust
toward perturbations of cell mass at the beginning of the cell division cycle all
contain a mass multiplication term in the synthesis reaction of the starter kinase.
This inclusion of this mass multiplication term to the starter kinase synthesis
reaction did, however, not necessarily lead to a correction mechanism in the G1
phase.
Mathematical models with more molecular detail have been published for
the G1/S transition7. In this model a critical cell mass (Ps) has to be reached
in order for the cells to start DNA replication. Furthermore the authors show
that the G1/S transition point is an emergent property arising from the detailed
interactions of the entire G1 to S network described in their model and that Ps is
determined by parameters such as binding affinity of individual cell cycle pro-
teins, which affect Ps independently from growth rate. Barberis et al. add several
novel features to their model to describe the G1 to S network in detail6,7. These
features include modeling of cell volume along with the explicit modeling of nu-
cleus and cytoplasm volume. With these additions the new model describes cyto-
plasmic synthesis of proteins, starting from mRNA migration from the nucleus.
Several other studies (such as Haberichter et al.33, Tashima et al.74 and Yao et
al.84) include additional G1 phase machinery in quantitative models. However,
these models describe the machinery active during the G1 phase (focussing on
the restriction point) and they can not be used to study the G1/S transition point.
This brings us back to the selection of models that we have included in our
comparative analysis. One could ask the question: Why did we not include
all the newest models with more molecular detail on specific aspects of the cell
cycle? The reason is simple; we compared the models with respect to the control
of the G1/S transition phase with a specific focus on robustness of cell size at
this transition. As such we were limited to cell cycle models that modeled the
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complete cell cycle (necessary for us to determine the fractional length of the
G1 phase to the total cell cycle length), and included the Cdh1 complex (used to
define the G1/S transition point), and mass (to check for the robustness of cell
size). We further limited ourselves to models for budding yeast and mammalian
cells, to compare robustness of mass at the G1/S phase transition for a system
where such a mass conservation has been proposed (yeast) to a system where the
existence of a mass-assessment checkpoint is debated.
In a concluding remark we wish to come back to the debate with which we
started this chapter: “Is there a mass-assessment checkpoint in the G1 phase
of mammalian cell lines?” On the basis of our comparative analysis of mathe-
matical models for the eukaryotic cell cycle, we could not find indications for
such a mass-assessment point in mammalian cells. Although the mass at the
G1/S restriction point was relatively robust to perturbations of the reactions in
the network, this robustness did not come from a regulatory mechanism in the
G1 phase, but was already present at the beginning of the G1 phase. This in
contrast to the budding yeast cell cycle, for which we observed a much stronger
robustness at the G1/S transition point compared to that at the beginning of the
G1 phase, suggesting that a mass-correction mechanism is in place in the G1
phase in these cells.
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5.8 Appendix 1
Table 5.2: Species occuring in the budding yeast cell cycle models. The
species as they occur in the Integrated cell cycle network are listed below,
along with the specie names as they occur in the original manuscripts where
the Csikasz, Chen, Chen2 and Tyson models were described. The budding
yeast models could all be constructed with 38 of the 54 variable species
from the integrated cell cycle network. Species that occured in all models
(highlighted in bold) were used to compare the respective models.
Budding Yeast Models
Specie Csikasz Chen Chen2 Tyson
BUD - BUD BUD -
C2 (CLB2/SIC1) CycB - actCycB -
preMPF
Clb2/Sic1 C2 -
C2p (CLB2/SIC1p) preMPF - CycB +
actCycB + TriB
- C2P -
C5 (CLB5/SIC1) CycA - actCycA Clb5/Sic1 C5 -
C5p (CLB5/SIC1p) - - C5P -
CDC14 Cdc20A - Cdc14 -
CDC15 - - Cdc15 -
CDC20A Cdc20A Cdc20 Cdc20A Cdc20A
CDC20I Cdc20T - Cdc20A Cdc20T - Cdc20 Cdc20T - Cdc20A Cdc20T - Cdc20A
CDC6 - - Cdc6 -
CDC6p - - Cdc6P -
CDH1A Cdh1 Hct1 Cdh1 Cdh1
CDH1I - - Cdh1T - Cdh1 -
CLB2 (clb2/cdk) actCycB Clb2T - Clb2/Sic1 Clb2 CycB
CLB2p CycB - actCycB -
TriB
- - -
CLB5 actCycA Clb5T - Clb5/Sic1 Clb5 -
CLN2 actCycE Cln2 Cln2 SK
ESP1 - - Esp1 -
F2 (CLB2/CDC6) - - F2 -
F2p (CLB2/CDC6p) - - F2P -
F5 (CLB5/CDC6) - - F5 -
F5p (CLB5/CDC6p) - - F5P -
IEP APCP - APC-P IE
MASS mass mass mass M
NET1 - - Net1 -
NET1p - - Net1T - Net1 -
Cdc14T + Cdc14
-
Continued on Next Page. . .
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Specie Csikasz Chen Chen2 Tyson
ORI - ORI ORI -
PDS1 - - Pds1 -
PE - - Esp1T - Esp1 -
PPX - - PPX -
RENT - - RENT -
RENTp - - Cdc14T - RENT -
Cdc14
SIC1 CKI - TriB - CycA
+ actCycA
Sic1T - Clb2/Sic1 -
Clb5/Sic1
Sic1 CKI
SIC1p - - Sic1P -
SPN - SPN SPN -
SWI5A - - Swi5 -
SWI5I - - Swi5T - Swi5 -
TEM1 - - Tem1 -
Table 5.3: Species occuring in the mammalian cell cycle models. The
species as they occur in the Integrated cell cycle network are listed below,
along with the specie names as they occur in the original manuscripts where
the Csikasz2, Novak, Conradie models were described. The mammalian
cell cycle models could all be constructed with 25 of the 54 variable species
from the integrated cell cycle network. Species that occured in all models
(highlighted in bold) were used to compare the respective models.
Mammalian cell Models
Specie Csikasz2 Novak Conradie
C5 (CLB5/SIC1) CycA - actCycA cycA:Kip1 cycA:Kip1
CDC14 Cdc20A - -
CDC20A Cdc20A Cdc20 Cdc20
CDC20I Cdc20T - Cdc20A Cdc20T - Cdc20 Cdc20T - Cdc20
CDH1A Cdh1 Cdh1 Cdh1
CLB2 (clb2/cdk) actCycB cycB cycB
CLB2p CycB - actCycB -
TriB
- -
CLB5 actCycA cycA cycA
CLN2 actCycE cycE cycE
CLN2/SIC1 CycE - actCycE cycE:Kip1 cycE:Kip1
CYCD - cycD cycD
CYCD/SIC1 - cycD:Kip1 cycD:Kip1
DRG - DRG DRG
E2F - E2F E2F
E2Fp - - E2Fp
Continued on Next Page. . .
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Specie Csikasz2 Novak Conradie
ERG - ERG ERG
GM - GM GM
IEP APCP IEP IEP
MASS mass mass mass
PPX - PPX PPX
Rb - - Rb
Rb/E2F - - Rb/E2F
Rb/pE2F - - Rb/pE2F
Rbp - - Rbp
SIC1 CKI - CycA -
CycE + actCycE
+ actCycA
Kip1 Kip1
Table 5.4: Species occuring in the general cell cycle models. The
species as they occur in the Integrated cell cycle network are listed below,
along with the specie names as they occur in the original manuscripts where
the Srividhya, Surovstev and Tyson2 models were described. The general
cell cycle models could all be constructed with 11 of the 54 variable species
from the integrated cell cycle network. Species that occured in all models
(highlighted in bold) were used to compare the respective models.
General cell cycle models
Specie Srividhya Surovstev Tyson2
CDC20A - Cdc20a Cdc20A
CDC20I - Cdc20 Cdc20T - Cdc20A
CDH1A APC-P Cdh1a Cdh1
CDH1I - Cdh1 -
cdk free Cdk - -
clb2 cyclin - -
CLB2 (clb2/cdk) MPF Clnb:Cdk CycB
IEP - - IE
MASS M Vcyt M
MIH1 Cdc25P - -
SWE1 Wee1 - -
Chapter 6
General discussion
In this thesis we addressed the following central research question: “Is it possible
to quantify the control exerted by the processes in the cell cycle network on the
checkpoints of G1/S transition?” For this we analyzed, within the framework
of MCA, several kinetic models for the cell cycle of mammalian and budding
yeast cells. We first developed an extension to the existing MCA framework
to quantify the control of dynamic systems (see Chapter 3). With this tool we
analyzed the control distribution for the positioning of the restriction point (RP,
a checkpoint in the G1 phase) in a mammalian cell cycle model. The results as
presented in Chapter 4, showed that several processes controlled the positioning
of RP, most notably those involved in: 1) the interaction between Rb and E2F
transcription factor; 2) the synthesis of DRG and Cyclin D/Cdk4 in response to
growth signals; 3) the E2F dependent Cyclin E/Cdk2 synthesis reaction; and 4)
p27 formation reaction. In Chapter 4 we also show that these processes likely
affect the restriction point via the Cyclin E/Cdk2:p27 complex.
We used an operational definition for the restriction point, with which we
could analyze the control distribution for this checkpoint. With respect to a mass
assessment checkpoint no such definition could be used; actually the existence
of a mass-assesment point in mammalian cells is a point of debate. To check
whether a mass-assessment point exists, we analyzed in a comparative study
between mammalian and budding yeast cell cycle models, the robustness of cell
78
Chapter 6. General discussion 79
size at the G1/S transition point (see Chapter 5). For this we first had to analyze
the control of the G1/S transition point. Strikingly, in all the detailed models
that were analyzed two reaction blocks had by far the strongest control on the
G1/S transition point, the first being the mass accumulation block and the second
the Clb2 synthesis and degradation block. In contrast to the similarity for the
control distribution on the G1/S transition point, no good agreement between
the mammalian cell cycle models and the yeast models was observed for the
robustness of cell size at the G1/S transition point. Our analysis showed that
in yeast a mass “correction” mechanism exists in the G1 phase that makes the
cell size at the G1/S transition point very robust to perturbations in the network
reactions. For mammalian cell cycle models we observed that the cell mass at
the G1/S transition point was not as robustly regulated as in the yeast models,
and we could not find indications of a “correction” mechanism; cell size at the
beginning of the G1 phase was equally robust for reaction perturbations as cell
size at the G1/S transition point.
Three core models did not display similar G1/S transition control distribu-
tions as were observed in the more detailed models. By adding a starter kinase
(Cln2) and a cyclin dependent kinase inhibitor (Sic1) to one of these core mod-
els, we showed in Chapter 5, that these two reactions changed the core model
such that it displayed the same control distribution on G1/S positioning (after
Cln2 addition) as was observed in the detailed models and made the model ro-
bust for cell size at the G1/S transition point (after both Cln2 and Sic1 were
added to the model). Here it should be noted that it is not just the presence of
Cln2 and Sic1 that leads to the changes in the core model, but more importantly
the way these components interact with the other components. Cln2 and Sic1
are present in both the mammalian and yeast models, but only in yeast does this
lead to cell-size stabilization at the G1/S transition point. This could be due to
the different roles the proteins play in these organisms, in yeast Sic1 stabilizes
Clb2 but not Cln2 while in mammalian cells this is exactly reversed (i.e. Sic1
stabilizes Cln2 but not Clb2).
In this thesis we have used a Systems Biology approach to address a num-
ber of key questions on control of the G1/S transition. Important for such an
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approach is the iterative cycle between theory, modeling and experiment. We
have here focused on the first two tiers of this cycle: theory development and
modeling analysis. We extended the MCA framework to include control anal-
ysis of dynamic systems, specifically the analysis of time dependent behavior
(e.g. species concentrations at a specific time point). This was an important
extension of the framework, which could only deal with time invariant behav-
ior (e.g. frequency of oscillation in the limit cycle). We have also developed
generic tools for model analysis: 1) we analyzed in detail how the control of
systems behavior by processes can be related to specific species in the system
(i.e. control of the restriction point via the CyclinE/Cdk2 complex) and 2) we
made a comparative analysis between a set of models, using a modular approach.
The first method is important to merge the MCA approach (analyzing systems
in terms of processes) and the traditional approach for dynamic systems analysis
(in terms of model species). The comparative analysis tool is important in view
of the large number of models that are being generated and stored in databases
but not compared. We have illustrated how model comparisons can be made,
even for models that differ largely in the detail with which the processes are
being modeled. We addressed specific problems in these comparisons: such as
testing whether a consensus view exists in the models on control distribution
of the G1/S transition point, or whether a mass assessment checkpoint exists in
mammalian cell cycle models.
We needed to select a subset of models to make the comparative analysis
useful. For instance the existence of certain species in the model if these are
essential for testing a hypothesis (e.g. mass is essential to test for robustness
of mass), or for defining a state in the system (e.g. Cdh1 decline marks the
G1/S transition point). Such a selection clearly limits the number of models
that can be included in the analysis (and thereby its generality), but it strength-
ens the analysis because more specific questions can be addressed. Although
the requirements for our model selection does not seem overly stringent, they
did limit us to a subset of models mainly produced by two research groups (the
Tyson group at Virginia Tech, USA and the Novak group, now at Oxford, UK).
The main reason for the restricted number of models was the requirement that
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the models should describe a complete cell cycle. Most of the models on the cell
cycle focus on a subset of the cell cycle. It would be an enormous improvement
if modeling efforts by groups could be combined, even if it were only by formu-
lating a very basic framework for the cell cycle. Such efforts would necessitate
standardization e.g. of units for rates and concentrations and an agreement must
be made for variable names, but these seem minimal efforts compared to the
hugh gain that could be made in a combined effort to modeling the cell cycle.
We have not extensively used the third tier of the iterative cycle: experimen-
tation. Of course experimentation was involved in construction of most of the
models that we have analyzed, and MCA makes a direct connection to experi-
mentation via its formulation in terms of perturbations of reaction steps, but we
have not focused on experimentation ourselves. Irrespective of this, we should
still discuss the relevance of our work for experimental cell cycle studies. One
of the most common approaches in experimental analysis of the cell cycle is the
use of knock-out mutants to study the role of a molecular specie. We should
stress that this approach is essentially different from the MCA approach towards
perturbations. Whereas in MCA infinitesimally small changes are made to study
the system at its physiological state, in a knock-out perturbation a component is
completely removed from the system thereby making a big change, which could
easily have moved the system far away from its physiological state. This could
lead to very different results, for instance in our MCA analysis on control of mass
at the transition point we observed that the three modules around active Cdc20,
Cln2 and CDh1 had the highest control. However, from knock-out studies on
these three components completely different results were obtained, and none of
these pointed at the role of the component in controlling mass5,23,70. More subtle
than deletion mutants would be the use of inhibitor titrations to study the role
of processes on systems behavior. Anti-cancer therapeutics, such as synthetic
cyclin-dependent kinase inhibitors have been used in cell cycle studies13. Such
inhibitor studies have as major advantages above deletion mutants that the sys-
tem can be studied at its physiological state and effects of small perturbations
can be inferred from extrapolation to a zero concentration of the inhibitor.
It has been argued that systems level modeling of the cell cycle requires the
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integration of ’omics’ data, such as proteomic data, with an appropriate mathe-
matical framework such as dynamic modeling46. To integrate such large data-
sets good mathematical analysis tools are essential, and these top-down and hy-
brid type of approaches are important to model whole cell behavior, for which
detailed molecular information is not available. In this thesis we have focused on
models that describe the cell cycle at a much lower level of detail, for the analysis
of which we used the mathematical framework of MCA. Whereas these models
do not describe enormous data-sets, they have been very useful for testing hy-
potheses on regulation and control of the G1/S transition state. We have stressed
in this thesis the role of model analysis and model comparison. These aspects
highlight additional roles for mathematical models, and we have demonstrated
how by using such analysis tools long standing debates can be addressed. For
instance, we tested whether we could find indications for a cell size controller
in the G1 phase of the cell cycle models. This is an open question, and still
very much under debate as indicated in the July 2009 issue of Science25,77 By
casting the question in the MCA framework, we could find a consensus answer
in our comparative approach: in yeast there appears to be such a mass assess-
ment point in the G1 phase while we could not find such a checkpoint in the
mammalian models.
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